UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended ~~September 30, 2022~~March 31, 2023

	OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from ________________ to ________________

Commission file number: 001-35774

INNODATA INC.

(Exact name of registrant as specified in its charter)

Delaware	13-3475943
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

55 Challenger Road	07660
Ridgefield Park, New Jersey	(Zip Code)
(Address of principal executive offices)

(201) 371-8000

(Registrant’s telephone number, including area code)

None

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	INOD	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☑ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The number of outstanding shares of the registrant’s common stock, $0.01 par value per share, as of ~~November 4, 2022~~May 5, 2023 was ~~27,378,234.~~27,549,984.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

For the Quarter Ended ~~September 30, 2022~~March 31, 2023

INDEX

	Part I – Financial Information
		Page No.
Item 1.	Financial Statements
	Condensed Consolidated Financial Statements (Unaudited):
	Condensed Consolidated Balance Sheets as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022	2
	Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~	3
	~~Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2022 and 2021~~	4
	Condensed Consolidated Statements of Cash Flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~	54
	Condensed Consolidated Statements of Stockholders’ Equity for the three a~~nd nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~	65
	Notes to Condensed Consolidated Financial Statements	76
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2425
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3537
Item 4.	Controls and Procedures	3537

	Part II – Other Information

Item 1.	Legal Proceedings	3638
Item 1A.	Risk Factors	3638
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3638
Item 3.	Defaults Upon Senior Securities	3638
Item 4.	Mine Safety Disclosures	3638
Item 5.	Other Information	3638
Item 6.	Exhibits	3739
Signatures		3840

Table of Contents

Part I. FINANCIAL INFORMATION

Item 1. Financial Statements

INNODATA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)

September 30,

December 31,

2022

2021
ASSETS




Current assets:




Cash and cash equivalents

$
10,729

$
18,902
Accounts receivable, net of allowance for doubtful accounts of $910 and $730 respectively

9,374

11,379
Prepaid expenses and other current assets

3,819

3,681
Total current assets

23,922

33,962
Property and equipment, net

2,718

2,947
Right-of-use-asset, net

4,199

5,621
Other assets

1,514

2,247
Deferred income taxes, net

1,532

1,950
Intangibles, net

11,942

10,347
Goodwill

1,982

2,143
Total assets

$
47,809

$
59,217

LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY




Current liabilities:




Accounts payable

$
2,952

$
1,823
Accrued expenses and other

6,738

7,564
Accrued salaries, wages and related benefits

6,911

6,391
Income and other taxes

2,991

3,213
Long-term obligations - current portion

596

1,279
Operating lease liability - current portion

742

1,034
Total current liabilities

20,930

21,304
Deferred income taxes, net

23

15
Long-term obligations, net of current portion

5,874

6,217
Operating lease liability, net of current portion

3,930

5,276
Total liabilities

30,757

32,812

Commitments and contingencies

Non-controlling interests

(729)

(3,522)




STOCKHOLDERS’ EQUITY:




Serial preferred stock; 4,998,000 shares authorized, none outstanding

-

-
Common stock, $.01 par value; 75,000,000 shares authorized; 30,556,000 shares issued and 27,372,000 outstanding at September 30, 2022 and 30,347,000 shares issued and 27,163,000 outstanding at December 31, 2021

306

303
Additional paid-in capital

34,846

35,121
Retained earnings (deficit)

(6,815)

3,160
Accumulated other comprehensive loss

(4,091)

(2,192)

24,246

36,392
Less: treasury stock, 3,184,000 shares at September 30, 2022 and December 31, 2021 at cost

(6,465)

(6,465)
Total stockholders’ equity

17,781

29,927
Total liabilities, non-controlling interests and stockholders’ equity

$
47,809

$
59,217


	March 31,		December 31,
	2023		2022
ASSETS
Current assets:
Cash and cash equivalents	$	10,330	$	9,792
Short term investments – other		512		507
Accounts receivable, net of allowance for doubtful accounts		8,462		9,528
Prepaid expenses and other current assets		4,189		3,858
Total current assets		23,493		23,685
Property and equipment, net		2,590		2,511
Right-of-use-asset, net		4,109		4,309
Other assets		2,252		1,498
Deferred income taxes, net		1,583		1,475
Intangibles, net		13,064		12,526
Goodwill		2,044		2,038
Total assets	$	49,135	$	48,042

LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	2,225	$	2,630
Accrued expenses and other		6,843		7,250
Accrued salaries, wages and related benefits		6,766		6,136
Income and other taxes		3,582		3,230
Long-term obligations - current portion		1,121		877
Operating lease liability - current portion		633		693
Total current liabilities		21,170		20,816
Deferred income taxes, net		57		65
Long-term obligations, net of current portion		6,288		5,079
Operating lease liability, net of current portion		3,926		4,036
Total liabilities		31,441		29,996

Commitments and contingencies
Non-controlling interests		(724)		(727)

STOCKHOLDERS’ EQUITY:
Serial preferred stock; 4,998,000 shares authorized, none outstanding		-		-
Common stock, $.01 par value; 75,000,000 shares authorized; 30,734,000 shares issued and 27,550,000 outstanding at March 31, 2023 and 30,589,000 shares issued and 27,405,000 outstanding at December 31, 2022		307		306
Additional paid-in capital		37,097		35,815
Deficit		(10,891)		(8,775)
Accumulated other comprehensive loss		(1,630)		(2,108)
		24,883		25,238
Less: treasury stock, 3,184,000 shares at March 31, 2023 and December 31, 2022 at cost		(6,465)		(6,465)
Total stockholders’ equity		18,418		18,773
Total liabilities, non-controlling interests and stockholders’ equity	$	49,135	$	48,042

See notes to Condensed Consolidated Financial Statements.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE LOSS

(Unaudited)

(In thousands, except per share amounts)


	Three Months Ended				Three Months Ended
	September 30,				March 31,
	2022		2021		2023		2022
Revenues	$	18,447	$	17,450	$	18,839	$	21,192
Operating costs and expenses:
Direct operating costs		12,389		10,703		12,874		13,414
Selling and administrative expenses		9,117		7,262		7,797		10,190
Interest expense, net		(1)		4		63		3
		21,505		17,969		20,734		23,607
Loss from operations		(3,058)		(519)
Loss before provision for income taxes						(1,895)		(2,415)
Provision for income taxes		268		328		218		475
Consolidated net loss		(3,326)		(847)		(2,113)		(2,890)
Income (loss) attributable to non-controlling interests		1		(47)		3		(75)
Net loss attributable to Innodata Inc. and Subsidiaries	$	(3,327)	$	(800)	$	(2,116)	$	(2,815)
Loss per share attributable to Innodata Inc. and Subsidiaries:
Basic and Diluted	$	(0.12)	$	(0.03)	$	(0.08)	$	(0.10)

Weighted average shares outstanding:
Basic and Diluted		27,331		26,971		27,460		27,158

Comprehensive Loss:
Consolidated Net loss	$	(3,326)	$	(847)	$	(2,113)	$	(2,890)
Pension liability adjustment, net of taxes		35		10		(5)		40
Foreign currency translation adjustment		(644)		(594)		60		(26)
Change in fair value of derivatives, net of taxes		(206)		(265)		423		5
Other comprehensive loss		(815)		(849)
Other comprehensive income						478		19
Total Comprehensive loss		(4,141)		(1,696)		(1,635)		(2,871)
Less: Comprehensive income (loss) attributable to non-controlling interest		1		(47)		3		(75)
Comprehensive Loss attributable to Innodata Inc. and Subsidiaries	$	(4,142)	$	(1,649)	$	(1,638)	$	(2,796)

See notes to Condensed Consolidated Financial Statements.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

~~CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND~~

~~COMPREHENSIVE LOSS~~

~~(Unaudited)~~

~~(In thousands, except per share amounts)~~

Nine Months Ended

September 30,

2022

2021
Revenues

$
59,626

$
50,466
Operating costs and expenses:

Direct operating costs

38,795

31,208
Selling and administrative expenses

29,584

19,767
Interest expense, net

1

18

68,380

50,993
Loss from operations

(8,754)

(527)
Gain from loan forgiveness

-

580
Income (loss) before provision for income taxes

(8,754)

53
Provision for income taxes

1,293

621
Consolidated net loss

(10,047)

(568)
Loss attributable to non-controlling interests

(72)

(63)
Net Loss attributable to Innodata Inc. and Subsidiaries

$
(9,975)

$
(505)

Loss per share attributable to Innodata Inc. and Subsidiaries:

Basic and Diluted

$
(0.37)

$
(0.02)

Weighted average shares outstanding:

Basic and Diluted

27,239

26,459

Comprehensive Loss:

Consolidated Net loss

$
(10,047)

$
(568)
Pension liability adjustment, net of taxes

113

32
Foreign currency translation adjustment

(1,270)

(480)
Change in fair value of derivatives, net of taxes

(742)

(532)
Other comprehensive loss

(1,899)

(980)
Total Comprehensive loss

(11,946)

(1,548)
Less: Comprehensive loss attributable to non-controlling interests

(72)

(63)
Comprehensive Loss attributable to Innodata Inc. and Subsidiaries

$
(11,874)

$
(1,485)

~~See notes to Condensed Consolidated Financial Statements.~~

~~Table of Contents~~

~~INNODATA INC. AND SUBSIDIARIES~~

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

Nine Months Ended

September 30,


2022

2021
Cash flows from operating activities:




Consolidated net loss

$
(10,047)

$
(568)
Adjustments to reconcile consolidated net loss to net cash provided by operating activities:

Depreciation and amortization

2,836

2,054
Gain on loan forgiveness

-

(580)
Stock-based compensation

2,370

1,117
Deferred income taxes

242

(16)
Pension cost

577

308
Loss on lease termination

125

-
Changes in operating assets and liabilities:

Accounts receivable

1,690

431
Prepaid expenses and other current assets

(235)

342
Other assets

734

214
Accounts payable and accrued expenses

(253)

2,895
Accrued salaries, wages and related benefits

498

976
Income and other taxes

(197)

(1,531)
Net cash provided by (used in) operating activities

(1,660)

5,642

Cash flows from investing activities:

Capital expenditures

(5,253)

(2,919)
Net cash used in investing activities

(5,253)

(2,919)

Cash flows from financing activities:




Proceeds from stock option exercises

276

2,214
Withholding taxes on net settlement of stock-based compensation

-

(763)
Payment of long-term obligations

(510)

(666)
Net cash provided by (used in) financing activities

(234)

785

Effect of exchange rate changes on cash and cash equivalents

(1,026)

(138)

Net increase (decrease) in cash and cash equivalents

(8,173)

3,370

Cash and cash equivalents, beginning of period

18,902

17,573

Cash and cash equivalents, end of period

$
10,729

$
20,943

Supplemental disclosures of cash flow information:

Shares withheld for withholding taxes on net settlement for stock-based compensation

$
-

$
763
Cash paid for income taxes

$
979

$
201
Cash paid for operating leases

$
1,424

$
1,312
Cash paid for interest

$
1

$
18


	Three Months Ended
	March 31,
	2023		2022
Cash flows from operating activities:
Consolidated net loss	$	(2,113)	$	(2,890)
Adjustments to reconcile consolidated net loss to net cash
provided by operating activities:
Depreciation and amortization		1,091		873
Stock-based compensation		962		537
Deferred income taxes		(94)		44
Pension cost		253		11
Loss on lease termination		-		125
Changes in operating assets and liabilities:
Accounts receivable		1,149		487
Prepaid expenses and other current assets		158		(63)
Other assets		21		144
Accounts payable, accrued expenses and other		(608)		(533)
Accrued salaries, wages and related benefits		627		(407)
Income and other taxes		338		176
Net cash provided by (used in) operating activities		1,784		(1,496)

Cash flows from investing activities:
Capital expenditures		(1,702)		(1,939)
Purchase of short term investments - others		(5)		-
Net cash used in investing activities		(1,707)		(1,939)

Cash flows from financing activities:
Proceeds from stock option exercises		321		26
Payment of long-term obligations		(70)		(39)
Redemption of non-controlling interest		-		1
Net cash provided by (used in) financing activities		251		(12)

Effect of exchange rate changes on cash and cash equivalents		210		(28)

Net increase (decrease) in cash and cash equivalents		538		(3,475)

Cash and cash equivalents, beginning of period		9,792		18,902

Cash and cash equivalents, end of period	$	10,330	$	15,427

Supplemental disclosures of cash flow information:
Vendor financed software licenses acquired	$	1,162	$	-
Non cash redemption of non-controlling interest	$	-	$	(2,864)
Cash paid for income taxes	$	24	$	308
Cash paid for operating leases	$	404	$	493
Cash paid for interest	$	92	$	4

See notes to Condensed Consolidated Financial Statements.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30,~~MARCH 31, 2023 AND 2022 ~~AND 2021~~

(Unaudited)

(In thousands)


								Accumulated														Accumulated
				Additional				Other										Additional		Retained		Other
	Common Stock			Paid-in		Retained		Comprehensive		Treasury Stock					Common Stock			Paid-in		Earnings		Comprehensive		Treasury Stock
	Shares	Amount		Capital		Earnings		Loss		Shares	Amount		Total		Shares	Amount		Capital		(Deficit)		Loss		Shares	Amount		Total
January 1, 2023															30,589	$	306	$	35,815	$	(8,775)	$	(2,108)	(3,184)	$	(6,465)	$	18,773
Net loss attributable to Innodata Inc. and subsidiaries															-		-		-		(2,116)		-	-		-		(2,116)
Stock-based compensation															-		-		962		-		-	-		-		962
Stock option exercises															148		1		320		-		-	-		-		321
Shares withheld for exercise net settlement															(3)		-		-		-		-	-		-		-
Pension liability adjustments, net of taxes															-		-		-		-		(5)	-		-		(5)
Foreign currency translation adjustment															-		-		-		-		60	-		-		60
Change in fair value of derivatives, net of taxes															-		-		-		-		423	-		-		423
March 31, 2023															30,734		307		37,097		(10,891)		(1,630)	(3,184)		(6,465)		18,418

January 1, 2022	30,347	$	303	$	35,121	$	3,160	$	(2,192)	3,184	$	(6,465)	$	29,927	30,347	$	303	$	35,121	$	3,160	$	(2,192)	(3,184)	$	(6,465)	$	29,927
Net loss attributable to Innodata Inc. and subsidiaries	-		-		-		(2,815)		-	-		-		(2,815)	-		-		-		(2,815)		-	-		-		(2,815)
Stock-based compensation	-		-		537		-		-	-		-		537	-		-		537		-		-	-		-		537
Stock option exercises	23		1		26		-		-	-		-		27	23		1		26		-		-	-		-		27
Shares withheld for exercise settlement and taxes	(7)		-		(53)		-		-	-		-		(53)
Shares withheld for taxes on restricted shares vesting															(7)		-		(53)		-		-	-		-		(53)
Redemption of non-controlling interest	-		-		(2,864)		-		-	-		-		(2,864)	-		-		(2,864)		-		-	-		-		(2,864)
Pension liability adjustments, net of taxes	-		-		-		-		40	-		-		40	-		-		-		-		40	-		-		40
Foreign currency translation adjustment	-		-		-		-		(26)	-		-		(26)	-		-		-		-		(26)	-		-		(26)
Change in fair value of derivatives, net of taxes	-		-		-		-		5	-		-		5	-		-		-		-		5	-		-		5
March 31, 2022	30,363	$	304	$	32,767	$	345	$	(2,173)	3,184	$	(6,465)	$	24,778	30,363		304		32,767		345		(2,173)	(3,184)		(6,465)		24,778
Net loss attributable to Innodata Inc. and subsidiaries	-		-		-		(3,833)		-	-		-		(3,833)
Stock-based compensation	-		-		1,028		-		-	-		-		1,028
Stock option exercises	124		1		152		-		-	-		-		153
Redemption of non-controlling interest	-		-		(1)		-		-	-		-		(1)
Pension liability adjustments, net of taxes	-		-		-		-		38	-		-		38
Foreign currency translation adjustment	-		-		-		-		(600)	-		-		(600)
Change in fair value of derivatives, net of taxes	-		-		-		-		(541)	-		-		(541)
June 30, 2022	30,487	$	305	$	33,946	$	(3,488)	$	(3,276)	3,184	$	(6,465)	$	21,022
Net loss attributable to Innodata Inc. and subsidiaries	-		-		-		(3,327)		-	-		-		(3,327)
Stock-based compensation	-		-		805		-		-	-		-		805
Stock option exercises	69		1		95		-		-	-		-		96
Pension liability adjustments, net of taxes	-		-		-		-		35	-		-		35
Foreign currency translation adjustment	-		-		-		-		(644)	-		-		(644)
Change in fair value of derivatives, net of taxes	-		-		-		-		(206)	-		-		(206)
September 30, 2022	30,556		306		34,846		(6,815)		(4,091)	3,184		(6,465)		17,781

January 1, 2021	28,984	$	289	$	31,921	$	4,833	$	(938)	3,184	$	(6,465)	$	29,640
Net income attributable to Innodata Inc. and subsidiaries	-		-		-		398		-	-		-		398
Stock-based compensation	-		-		278		-		-	-		-		278
Exercise of stock options	690		4		605		-		-	-		-		609
Shares withheld for exercise settlement and taxes	(193)		1		(764)		-		-	-		-		(763)
Pension liability adjustments, net of taxes	-		-		-		-		11	-		-		11
Foreign currency translation adjustment	-		-		-		-		(21)	-		-		(21)
March 31, 2021	29,481	$	294	$	32,040	$	5,231	$	(948)	3,184	$	(6,465)	$	30,152
Net loss attributable to Innodata Inc. and subsidiaries	-		-		-		(103)		-	-		-		(103)
Stock-based compensation	-		-		336		-		-	-		-		336
Exercise of stock options	556		5		1,136		-		-	-		-		1,141
Pension liability adjustments, net of taxes	-		-		-		-		11	-		-		11
Foreign currency translation adjustment	-		-		-		-		135	-		-		135
Change in fair value of derivatives, net of taxes	-		-		-		-		(267)	-		-		(267)
June 30, 2021	30,037	$	299	$	33,512	$	5,128	$	(1,069)	3,184	$	(6,465)	$	31,405
Net loss attributable to Innodata Inc. and subsidiaries	-		-		-		(800)		-	-		-		(800)
Stock-based compensation	-		-		503		-		-	-		-		503
Exercise of stock options	300		4		460		-		-	-		-		464
Pension liability adjustments, net of taxes	-		-		-		-		10	-		-		10
Foreign currency translation adjustment	-		-		-		-		(594)	-		-		(594)
Change in fair value of derivatives, net of taxes	-		-		-		-		(265)	-		-		(265)
September 30, 2021	30,337		303		34,475		4,328		(1,918)	3,184		(6,465)		30,723

See notes to Condensed Consolidated Financial Statements.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

1. Summary of Significant Accounting Policies and Estimates

Basis of Presentation - The condensed consolidated financial statements for the interim periods included herein are unaudited; however, they contain all adjustments (consisting of only normal recurring adjustments) that, in the opinion of management, are necessary to present fairly the consolidated financial position of Innodata Inc. (including its subsidiaries, the “Company”) as of ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021,~~2022, the results of its operations and comprehensive loss for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ cash flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ and stockholders’ equity for the three ~~and nine~~ months ended ~~September 30, 2022~~March 31, 2023 and ~~2021.~~2022. The results of operations for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year.

Certain information and note disclosures normally included in or with financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted from these condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022. Unless otherwise noted, the accounting policies used in preparing these condensed consolidated financial statements are the same as those described in the notes to the consolidated financial statements for the year ended December 31, ~~2021.~~2022.

Principles of Consolidation - The condensed consolidated financial statements include the accounts of Innodata Inc. and its wholly owned subsidiaries, and docGenix, a limited liability company that is majority-owned by the Company. The non-controlling interest in the docGenix limited liability company has call and put options that can be settled in cash or stock. Accordingly, this is presented in temporary equity in accordance with the Financial Accounting Standards Board’s (the “FASB”) non-controlling interest guidance. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates - In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Management believes that the estimates and assumptions used in the preparation of the condensed consolidated financial statements are ~~reasonable, including assumptions made by management about the possible effects of the novel coronavirus (“COVID-19”) pandemic on critical and significant accounting estimates.~~reasonable. Actual results could differ from those estimates. Significant estimates include those related to the allowance for doubtful accounts and billing adjustments, useful life of long-lived assets, useful life of intangible assets, impairment of goodwill and intangible assets, valuation of deferred tax assets, valuation of stock-based compensation, pension benefit plan assumptions, litigation accruals and estimated accruals for various tax exposures.

Revenue Recognition – The Company’s revenue is recognized when services are rendered or goods are delivered to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services or goods as per the agreement with the customer. In cases where there are agreements with multiple performance obligations, the Company identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the agreement at the agreement’s inception. Performance obligations that are not distinct at agreement inception are combined. For agreements with distinct performance obligations, the Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation, if any, and then evaluates how the services are performed for the customer to determine the timing of revenue recognition.

For the Digital Data Solutions (DDS) segment, revenue is recognized primarily based on the quantity delivered or resources utilized in the period in which services are performed and performance conditions are satisfied as per the agreement. Revenue from agreements billed on a time-and-materials basis is recognized as services are performed. Revenue from fixed-fee agreements, which ~~are~~is not significant to overall revenues, is recognized based on the proportional performance method of accounting, as services are performed, or milestones are achieved.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

For the Synodex segment, revenue is recognized primarily based on the quantity delivered in the period in which services are performed and performance conditions are satisfied as per the agreement. A portion of the Synodex segment revenue is derived from licensing the Company’s functional software and providing access to the Company’s hosted software platform. Revenue from such services is recognized monthly when all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; access to the service is provided to the end user; and collection is probable.

The Agility segment derives its revenue primarily from subscription arrangements and provision of enriched media analysis services. It also derives revenue as a reseller of corporate communication solutions. Revenue from subscriptions is recognized monthly when access to the service is provided to the end user; all parties to the agreement have agreed to the agreement; each party’s rights are identifiable; the payment terms are identifiable; the agreement has commercial substance; and collection is probable. Revenue from enriched media analysis services is recognized when the services are performed, and performance conditions are satisfied. Revenue from the reseller agreements is recognized at the gross amount received for the goods in accordance with the Company functioning as a principal due to the Company meeting the following criteria: the Company acts as the primary obligor in the sales transaction; assumes the credit risk; sets the price; can select suppliers; and is involved in the execution of the services, including after sales service.

Revenue includes reimbursement of out-of-pocket expenses, with the corresponding out-of-pocket expenses included in direct operating costs.

Revenue associated with the services provided in one period and billed in a subsequent period is commonly referred to as unbilled revenues and ~~are~~is included under Accounts receivable.

The Company considers U.S. GAAP criteria for determining whether to report gross revenue as a principal versus net revenue as an agent. The Company evaluates whether it is in control of the services before the same are transferred to the customer to assess whether it is principal or agent in the arrangement. ~~Revenue is recognized on a gross basis if the Company is in the capacity of principal and on a net basis if it falls in the capacity of an agent.~~

Contract acquisition costs, which are included in prepaid expenses and other current assets, are amortized over the term of a subscription agreement or contract that normally has a duration of 12 months or less. The Company reviews these prepaid acquisition costs on a periodic basis to determine the need to adjust the carrying values for early-terminated contracts. Included in prepaid expenses and other current assets on the accompanying condensed consolidated balance sheets are contract acquisition costs amounting to $0.7 million and $0.8 million as of March 31, 2023 and December 31, 2022, respectively. These acquisition costs relate to our Agility segment and are amortized over the term of the subscription agreement which normally has a duration of 12 months or less.

Foreign Currency Translation - The functional currency of the Company’s ~~locations~~subsidiaries in the Philippines, India, Sri Lanka, Israel, Hong Kong and Canada (other than the Agility subsidiary) is the U.S. dollar. Transactions denominated in Philippine pesos, Indian and Sri Lankan rupees, Israeli shekels, and Hong Kong and Canadian dollars are translated to U.S. dollars at rates which approximate those in effect on the transaction dates. Monetary assets and all liabilities denominated in foreign currencies on ~~September 30, 2022~~March 31, 2023 and December 31, ~~2021~~2022 are translated at the exchange rate in effect as of those dates. Non-monetary assets and stockholders’ equity are translated at the appropriate historical rates. Included in direct operating costs were foreign exchange losses (gains) resulting from such transactions of approximately $309,000 and ($419,000) for the three months ended March 31, 2023 and 2022, respectively.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The functional currency for the Company’s subsidiaries in Germany, the United Kingdom and for the Company’s Agility subsidiary in Canada are the Euro, the Pound Sterling and the Canadian dollar, respectively. The financial statements of these subsidiaries are prepared in ~~these~~their respective currencies. Financial information is translated from the applicable functional currency to the U.S. dollar (the reporting currency) for inclusion in the Company’s condensed consolidated financial statements. Income, expenses and cash flows are translated at weighted-average exchange rates prevailing during the fiscal period, and assets and liabilities are translated at fiscal period-end exchange rates. Resulting translation adjustments are included as a component of accumulated other comprehensive loss in stockholders’ equity. Foreign exchange transaction gains or losses are included in direct operating costs in the accompanying condensed consolidated statements of operations and comprehensive loss.

Included in direct operating costs were foreign exchange gains resulting from such transactions of approximately $729,000 and $348,000 for the three months ended September 30, 2022 and 2021 respectively and $1,896,000 and $503,000 for the nine months ended September 30, 2022 and 2021 respectively.

~~Table of Contents~~

~~INNODATA INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

~~(Unaudited)~~

Derivative Instruments - The Company accounts for derivative transactions in accordance with the FASB’s Accounting Standards Codification (“ASC”) Topic 825, “Financial Instruments”. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded in Other comprehensive ~~loss. Upon settlement of these contracts,~~income (loss). When the ~~change in the fair value~~amounts recorded in Other comprehensive ~~loss is~~income (loss) are reclassified to earnings, ~~and~~they are included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

Capitalized Developed Software - The Company incurs development costs related to software it develops for its internal use. Qualifying costs incurred during the application development stage are capitalized. These costs primarily consist of internal labor and third-party development costs and are amortized using the straight-line method over the estimated useful life of the capitalized developed software, which generally ranges ~~between~~from three ~~and~~to ten years. All other research and maintenance costs are expensed as incurred.

Income Taxes - Estimated deferred taxes are determined based on the difference between the financial statement and tax basis of assets and liabilities, using enacted tax rates, as well as any net operating loss or tax credit carryforwards expected to reduce taxes payable in future years. A valuation allowance is provided when it is more likely than not that all or some portion of the estimated deferred tax assets will not be realized. While the Company considers future taxable income in assessing the need for the valuation allowance, in the event that the Company anticipates that it will be able to realize the estimated deferred tax assets in the future in excess of its net recorded amount, an adjustment to the provision for deferred tax assets would increase income in the period such determination was made. Similarly, in the event that the Company anticipates that it will not be able to realize the estimated deferred tax assets in the future considering future taxable income, an adjustment to the provision for deferred tax assets would decrease income in the period such determination was made. In assessing the realization of deferred tax assets, management considered whether it is more likely than not that all or some portion of the United States, Canadian and European (principally Germany and the United Kingdom) deferred tax assets will not be realizable. As the expectation of future taxable income cannot be predicted with certainty, the Company maintains a valuation allowance against all the United States, Canadian and European (principally Germany and the United Kingdom) net deferred tax assets. Changes in the valuation allowance from period to period are included in the Company’s tax provision in the period of change.

The Company indefinitely reinvests the foreign earnings in its foreign subsidiaries. If such earnings are repatriated in the future, or are no longer deemed to be indefinitely reinvested, the Company would have to accrue as a liability the applicable amount of foreign jurisdiction withholding taxes associated with such remittances.

In assessing the realization of deferred tax assets, management considered whether it is more likely than not that all or some portion of the U.S. and Canadian deferred tax assets will not be realizable. As the expectation of future taxable income resulting from the U.S. and Canadian entities is not probable at this time, the Company maintains a valuation allowance against all the U.S. and Canadian net deferred tax assets.

The Company accounts for income taxes regarding uncertain tax positions, and recognizes interest and penalties related to uncertain tax positions in income tax expense in the condensed consolidated statements of operations and comprehensive loss.

~~Deferred Revenue~~ - Deferred revenue represents payments received from customers in advance of providing services and amounts deferred if conditions for revenue recognition have not been met. Included in accrued expenses and other on the accompanying condensed consolidated balance sheets is deferred revenue amounting to $2.6 million and $4.5 million as of September 30, 2022 and December 31, 2021, respectively. The Company expects to recognize substantially all of these performance obligations over the next 12 months.

~~Recent Accounting Pronouncements~~ – In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Statements” (“ASU 2016-13”). ASU 2016-13 requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation amount that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. In November 2018, the FASB issued ASU No. 2018-19, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses,” which clarifies ASC Topic 326, “Financial Instruments – Credit Losses” and corrects unintended application of the guidance, and in November 2019, the FASB issued ASU No. 2019-11, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses,” which clarifies or addresses specific issues about certain aspects of ASU 2016-13. In March 2020, the FASB issued ASU No. 2020-03, “Codification Improvements to Financial Instruments,” which modifies the measurement of expected credit losses of certain financial instruments. ASU 2016-13 is effective for certain smaller reporting companies for financial statements issued for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years, which will be fiscal 2023 for the Company if it continues to be classified as a smaller reporting company, with early adoption permitted. The Company does not expect that the adoption of the new guidance will have a material impact on the Company’s condensed consolidated financial statements.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE~~(Unaudited)

Deferred Revenue - Deferred revenue represents advance billings made to customers where conditions for revenue recognition have not been met. These amounts are included in accrued expenses and other on the accompanying condensed consolidated balance sheets. We expect to recognize substantially all of these performance obligations over the next 12 months. The table below provides information about contract liabilities (deferred revenue) and the significant changes in the balance for the three months ended March 31, 2023 (in thousands):


	Amount
Balance at December 31, 2022	$	4,366
Net deferred revenue in the period		2,585
Revenue recognized		(2,744)
Currency translations and other adjustments		(18)
Balance at March 31, 2023	$	4,189

2. Short Term Investments – other

The Short-term investments include investments made by the Company in treasury bills and certificates of deposit which are considered as highly liquid investments having a maturity period of less than one year.


	March 31,		December 31,
	2023		2022
Treasury bills	$	499	$	494
Certificates of deposit		13		13
Total	$	512	$	507

3. Accounts Receivable

Accounts receivable consists of the following:


	March 31,		December 31,
	2023		2022
Gross Accounts receivable	$	9,628	$	10,741
Allowance for doubtful accounts		(1,166)		(1,213)
Accounts receivable, net	$	8,462	$	9,528

As of January 1, 2023, the Company has adopted ASU 2019-04 (Codification Improvements to Topic 326, Financial Instruments—Credit Losses), and based on its assessment there was no impact on the financial statements or other related disclosures. The basis of allowance for doubtful accounts remains similar to the earlier adopted estimation procedure which is further elaborated in the paragraph below.

We maintain an allowance for credit losses for estimated losses resulting from the failure of our customers to make the required payments and provisions for billing adjustments relating to quality issues on delivered services. The allowance for credit losses is based on a review of specifically identified accounts and an overall aging analysis applied to accounts pooled based on similar risk characteristics. Judgments are made with respect to the collectability of accounts receivable within each pool based on historical experience, current payment practices, and current economic trends based on our expectations over the expected life of the receivables, generally ninety days or less. Actual credit losses could differ from those estimates.

Table of Contents

INNODATA INC. AND ~~NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

2.Activity in the allowance for the credit losses for the three months ended March 31, 2023 was as follows (in thousands):


	Amount
Balance at January 1, 2023	$	1,213
Additions charged to expense		180
Write-offs against allowance		(230)
Foreign currency translation adjustment		3
Balance at March 31, 2023	$	1,166

4. Goodwill and Intangible Assets

~~Goodwill~~

As of September 30, 2022, the Company performed its annual goodwill impairment analysis on one of its reporting units, the Agility segment. The Company also tested for impairment intangible assets for the Agility and Synodex segments. The impairment test involves estimating the fair value based on a combination of income (estimates of future discounted cash flows) and the market approach (market multiples for similar companies) using unobservable inputs (Level 3). The income approach uses a discounted cash flow (“DCF”) method that utilizes the present value of cash flows to estimate the segment’s fair value. The future cash flows of the segment were projected based on the Company’s estimates of future revenue, operating income, and other factors such as working capital and capital expenditures. As part of the DCF analysis, the Company projected revenue and operating profits and assumed long-term revenue growth rates in the terminal year. The market approach utilizes multiples of revenues and earnings before interest expense, taxes, depreciation, and amortization (“EBITDA”) to estimate the segment’s fair value. The market multiples used for the segment were based on a group of comparable companies’ market multiples applied to the Company’s revenue. The Company concluded that there is no impairment of goodwill and intangible assets for the Agility and Synodex segments.

The change in the carrying amount of goodwill for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 was as follows (in thousands):


Balance as of January 1, 2022	$	2,143
Balance as of January 1, 2023			$	2,038
Foreign currency translation adjustment		(161)		6
Balance as of September 30, 2022	$	1,982
Balance as of March 31, 2023			$	2,044

The fair value measurement of goodwill for the Agility segment was classified within Level 3 of the fair value hierarchy because the Company used the income approach, which utilizes significant inputs that are unobservable in the market and the market multiple approach ~~which utilizes~~using comparable entities to further validate the carrying values. The Company believes it made reasonable estimates and assumptions to calculate the fair value of the reporting unit as of the impairment test measurement date. The carrying value of Goodwill was $2.0 million as of March 31, 2023, and December 31, 2022.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

~~Intangibles~~

Information regarding the Company acquired intangible assets and capitalized developed software was as follows (in thousands):

Capitalized Developed

Company Acquired Intangible Assets

Software

Capitalized

Trademarks

Media

Capitalized

Developed

Developed

Customer

and

Contact

Developed

Software - in


technology

relationships

tradenames

Patents

Database

Software

Progress

Total
Gross carrying amounts:

Balance as of January 1, 2022

$
3,169

$
2,228

$
880

$
45

$
3,648

$
8,576

$
635

$
19,181
Additions

-

-

-

-

-

-

4,244

4,244
Transfers

-

-

-

-

-

2,882

(2,882)

-
Foreign currency translation

(235)

(162)

(42)

(3)

(284)

(656)

(12)

(1,394)
Balance as of September 30, 2022

$
2,934

$
2,066

$
838

$
42

$
3,364

$
10,802

$
1,985

$
22,031

Accumulated amortization:
















Balance as of January 1, 2022

$
2,158

$
1,377

$
685

$
34

$
2,005

$
2,575

$
-

$
8,834
Amortization expense

235

139

42

3

267

1,286

-

1,972
Foreign currency translation

(175)

(110)

(30)

(3)

(170)

(229)

-

(717)
Balance as of September 30, 2022

$
2,218

$
1,406

$
697

$
34

$
2,102

$
3,632

$
-

$
10,089

Net carrying values - September 30, 2022

$
716

$
660

$
141

$
8

$
1,262

$
7,170

$
1,985

$
11,942


	March 31, 2023
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	2,999	$	(2,414)	$	1	$	586
Customer relationships		2,096		(1,514)		-		582
Trademarks and tradenames		852		(733)		-		119
Patents		43		(37)		-		6
Media Contact Database		3,492		(2,357)		6		1,141
Total Acquired Intangible Assets	$	9,482	$	(7,055)	$	7	$	2,434

Capitalized Developed Software
Capitalized Developed Software	$	11,778	$	(4,779)	$	3	$	7,002
Capitalized Developed Software - in Progress		3,631		-		(3)		3,628
Total Capitalized Developed Software	$	15,409	$	(4,779)	$	-	$	10,630

Total	$	24,891	$	(11,834)	$	7	$	13,064

Company Acquired Intangible Assets

Capitalized Developed Software

Capitalized

Trademarks

Media

Capitalized

Developed

Developed

Customer

and

Contact

Developed

Software - in


technology

relationships

tradenames

Patents

Database

Software

Progress

Total
Gross carrying amounts:












Balance as of January 1, 2021

$
3,175

$
2,228

$
882

$
45

$
3,670

$
5,507

$
1,360

$
16,867
Additions

-

-

-

-

-

376

2,005

2,381
Transfers

-

-

-

-

-

2,752

(2,752)

-
Foreign currency translation adjustment

(6)

-

(2)

-

(22)

(59)

22

(67)
Balance as of December 31, 2021

$
3,169

$
2,228

$
880

$
45

$
3,648

$
8,576

$
635

$
19,181

Accumulated amortization:

Balance as of January 1, 2021

$
1,844

$
1,192

$
629

$
29

$
1,650

$
1,492

$
-

$
6,836
Amortization expense

315

187

56

5

354

1,089

-

2,006
Foreign currency translation adjustment

(1)

(2)

-

-

1

(6)

-

(8)
Balance as of December 31, 2021

$
2,158

$
1,377

$
685

$
34

$
2,005

$
2,575

$
-

$
8,834

Net carrying amounts - December 31, 2021

$
1,011

$
851

$
195

$
11

$
1,643

$
6,001

$
635

$
10,347


	December 31, 2022
					Foreign
	Gross				Currency		Net
	Carrying		Accumulated		Translation		Carrying
	Value		Amortization		Adjustment		Value
Acquired Intangible Assets
Developed technology	$	3,169	$	(2,468)	$	(43)	$	658
Customer relationships		2,228		(1,560)		(42)		626
Trademarks and tradenames		880		(740)		(8)		132
Patents		45		(38)		1		8
Media Contact Database		3,648		(2,358)		(68)		1,222
Total Acquired Intangible Assets	$	9,970	$	(7,164)	$	(160)	$	2,646

Capitalized Developed Software
Capitalized Developed Software	$	11,845	$	(4,398)	$	(348)	$	7,099
Capitalized Developed Software - in Progress		2,787		-		(6)		2,781
Total Capitalized Developed Software	$	14,632	$	(4,398)	$	(354)	$	9,880

Total	$	24,602	$	(11,562)	$	(514)	$	12,526

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

Amortization expense relating to acquired intangible assets was $0.2 million for each of the three-month periods ended March 31, 2023 and ~~$0.7 million for the three and nine months ended September 30, 2022.~~2022, respectively.

Amortization expense relating to capitalized developed software was ~~$0.5~~$0.6 million and ~~$1.3~~$0.4 million for the three ~~and nine~~ months ended ~~September 30, 2022.~~March 31, 2023 and 2022, respectively.

As of ~~September 30, 2022,~~March 31, 2023, estimated future amortization expense for intangible assets was as follows (in thousands):


Year	Amortization		Amortization
2022	$	761
2023	$	3,579	$	3,623
2024	$	3,124		3,975
2025	$	2,217		3,054
2026	$	818		853
2027				460
Thereafter	$	1,443		1,099
	$	11,942	$	13,064

3.5. Income Taxes

Taxes primarily consist of a provision for foreign taxes recorded by the Company’s foreign subsidiaries in accordance with local tax regulations. Effective income tax rates are disproportionate due to the losses incurred by the Company’s ~~U.S.~~United States, Canadian, German and ~~Canadian~~the United Kingdom subsidiaries and a valuation allowance recorded on deferred taxes of these entities and tax effects of foreign operations, including foreign exchange gains and losses.

The reconciliations of the U.S. statutory rate with the Company’s effective tax rate for the ~~nine-month periods~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021~~respectively, are summarized in the table below:


	For the Nine Months				For the Three Months
	Ended September 30,				Ended March 31,
	2022		2021		2023		2022
Federal income tax expense at statutory rate	(21.0)	%	21.0	%	(21.0)	%	(21.0)	%
Effect of:
Change in valuation allowance	43.0		2,468.8		23.8		35.1
Tax effects of foreign operations	1.1		79.8		3.8		5.9
Increase (decrease) in unrecognized tax benefits (ASC 740)	1.0		(490.0)
Foreign operations permanent difference - foreign exchange gains and losses					3.5		4.4
Increase in unrecognized tax benefits (ASC 740)					3.4		1.1
Foreign rate differential					0.9		(8.0)
State income tax net of federal benefit					0.3		0.2
Return to provision true up	0.2		31.6		(0.4)		4.7
State income tax net of federal benefit	0.2		43.2
Section 162 (m)	-		549.9
Change in tax rates	-		225.0
Effect of stock based compensation	(0.4)		(1,573.2)		(1.4)		-
Foreign operations permanent difference - foreign exchange gains and losses	(1.5)		271.9
Foreign rate differential	(5.8)		(478.8)
Withholding tax	-		-
Deemed interest					(4.6)		(2.6)
Other	(2.0)		22.5		3.2		(0.1)
Effective tax rate	14.8	%	1,171.7	%	11.5	%	19.7	%

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

The following table presents a roll-forward of the Company’s unrecognized tax benefits and associated interest for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 (in thousands):


	Unrecognized		Unrecognized
	tax benefits		tax benefits
Balance - January 1, 2022	$	1,753
Balance - January 1, 2023			$	1,680
Increase for current period tax positions		83		44
Decrease for prior period tax positions		(29)
Interest accrual		46		21
Foreign currency remeasurement		(177)		9
Balance - September 30, 2022	$	1,676
Balance - March 31, 2023			$	1,754

The Company expects that unrecognized tax benefits as of ~~September 30, 2022,~~March 31, 2023, if recognized, would have a material impact on the Company’s effective tax rate.

Tax Assessments

In September 2015, the Company’s Indian subsidiary was subject to an inquiry by the Service Tax Department in India regarding the classification of services provided by this subsidiary, asserting that the services provided by this subsidiary fall under the category of online information and database access or retrieval services (OID Services), and not under the category of business support services (BS Services) that are exempt from service tax as historically indicated in the subsidiary’s service tax filings. The Company disagrees with the Service Tax Department’s position. In November 2019, the Commissioner of Central Tax, GST & Central Excise issued an order confirming the Service Tax Department’s position. The Company is contesting this order in an appeal to the Customs, Excise and Service Tax Appellate Tribunal. In the event the Service Tax Department is ultimately successful in proving that the services fall under the category of OID Services, the revenues earned by the Company’s Indian subsidiary for the period July 2012 through November 2016 would be subject to a service tax of between 12.36% and 15%, and this subsidiary may also be liable for interest and penalties. The revenue of the Company’s Indian subsidiary during this period was approximately ~~$53.0~~$57.0 million. In accordance with new rules promulgated by the Service Tax Department, as of December 1, 2016 service tax is no longer applicable to OID or BS Services. Based on the Company’s assessment in consultation with the Company’s tax counsel, the Company has not recorded any tax liability for this case.

In a separate action relating to service tax refunds, in October 2016, the Company’s Indian subsidiary received notices from the Indian Service Tax Department in India seeking to reverse service tax refunds of approximately ~~$160,000~~$121,000 previously granted to the Company’s Indian subsidiary for three quarters in 2014, asserting that the services provided by this subsidiary fall under the category of OID Services and not BS Services. The appeal was determined in favor of the Service Tax Department. The Company disagrees with the basis of this decision and is contesting it. The Company expects delays in its Indian subsidiary receiving further service tax refunds until this matter is adjudicated with finality, and currently has service tax credits of approximately ~~$0.9~~$0.8 million recorded as a receivable. Based on the Company’s assessment in consultation with the Company’s tax counsel, the Company has not recorded any tax liability for this case.

Substantial recovery against the Company in the above referenced 2015 Service Tax Department case could have a material adverse impact on the Company, and unfavorable rulings or recoveries in other tax proceedings could have a material adverse impact on the consolidated operating results of the period (and subsequent periods) in which the rulings or recovery occurs.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE~~(Unaudited)

6. Operating Leases

The Company has various lease agreements for its offices and service delivery centers. The Company has determined that the risks and benefits related to the leased properties are retained by the lessors. Accordingly, these are accounted for as operating leases.

These lease agreements are for terms ranging from two to eleven years and, in most cases, provide for rental escalations ranging from 1.75% to 10%. Most of these agreements are renewable at the mutual consent of the parties to the contract.

The table below summarizes the amounts recognized in the condensed consolidated financial statements related to operating leases for the periods presented (in thousands):


	For the Three Months Ended
	March 31,
	2023		2022
Rent expense for long-term operating leases	$	309	$	376
Rent expense for short-term leases		95		117
Total rent expense	$	404	$	493

The following table presents the maturity profile of the Company’s operating lease liabilities based on the contractual undiscounted payments with a reconciliation of these amounts to the remaining net present value of the operating lease liability reported in the condensed consolidated balance sheet as of March 31, 2023 (in thousands):


Year	Amount
2023	$	761
2024		858
2025		890
2026		927
2027		912
2028 and thereafter		1,553
Total lease payments		5,901
Less: Interest		(1,342)
Net present value of lease liabilities	$	4,559

Current portion	$	633
Long-term portion		3,926
Total	$	4,559

The weighted average remaining lease terms and discount rates for all of the Company’s operating leases as of March 31, 2023 were as follows:


Weighted-average lease term remaining (in months)	49
Weighted-average discount rate	9.10	%

Table of Contents

INNODATA INC. AND ~~NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

4.7.Long-term obligations

Total long-term obligations as of March 31, 2023 and December 31, 2022 consisted of the following (in thousands):


	March 31,		December 31,
	2023		2022
Pension obligations - accrued pension liability	$	6,239	$	5,906
Settlement agreement		-		50
Microsoft licenses ⁽¹⁾		1,170		-
		7,409		5,956
Less: Current portion of long-term obligations		1,121		877
Totals	$	6,288	$	5,079

⁽¹⁾ In March 2023, the Company renewed a vendor agreement to acquire certain additional software licenses, receive technical support and future software upgrades on software licenses through February 2026. Pursuant to this agreement, the Company is contractually liable to pay approximately $0.4 million annually over the term of the agreement.

8. Commitments and Contingencies

Litigation – In 2008, a judgment was rendered in the Philippines against a Philippine subsidiary of the Company that is no longer active and purportedly also against Innodata Inc., in favor of certain former employees of the Philippine subsidiary. The potential payment amount aggregates to approximately ~~$6.8~~$5.9 million, plus legal interest that accrued at 12% per annum from August 13, 2008 to June 30, 2013, and thereafter accrued and continues to accrue at 6% per annum. The potential payment amount as expressed in U.S. dollars varies with the Philippine peso to U.S. dollar exchange rate. In December 2017, a group of 97 of the former employees of the Philippine subsidiary indicated that they proposed to record the judgment as to themselves in New Jersey. In January 2018, in response to an action initiated by Innodata Inc., the United States District Court for the District of New Jersey (“USDC”) entered a preliminary injunction that enjoins these former employees from pursuing or seeking recognition or enforcement of the judgment against Innodata Inc. in the United States during the pendency of the action and until further order of the USDC. In June 2018, the USDC entered a consent order administratively closing the action subject to return of the action to the active docket upon the written request of Innodata Inc. or the former employees, with the USDC retaining jurisdiction over the matter and the preliminary injunction remaining in full force and effect.

The Company is also subject to various other legal proceedings and claims that have arisen in the ordinary course of business.

While management currently believes that the ultimate outcome of these proceedings will not have a material adverse effect on the Company’s consolidated financial position or overall trends in consolidated results of operations, litigation is subject to inherent uncertainties. Substantial recovery against the Company in the above-referenced Philippine action could have a material adverse impact on the Company, and unfavorable rulings or recoveries in the other proceedings could have a material adverse impact on the consolidated operating results in the period in which the ruling or recovery occurs. In addition, the Company’s estimate of the potential impact on the Company’s consolidated financial position or overall consolidated results of operations for the above referenced legal proceedings could change in the future.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The Company’s legal accruals related to legal proceedings and claims are based on the Company’s determination of whether or not a loss is probable. The Company reviews outstanding proceedings and claims with external counsel to assess probability and estimates of loss. The accruals are adjusted if necessary. While the Company intends to defend these matters vigorously, adverse outcomes that it estimates could reach approximately ~~$350,000~~$450,000 in the aggregate beyond recorded amounts are reasonably possible. If circumstances change, the Company may be required to record adjustments that could be material to its reported consolidated financial condition and results of operations.

5.9. Stock Options and Restricted Stock Units

A summary of option activity under the Innodata Inc. 2013 Stock Plan, as amended and restated effective June 7, 2016 (the “2013 Plan”) and changes during each of the ~~nine-month~~three-month periods ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ are presented below:


		Weighted - Average		Weighted-Average						Weighted-Average
	Number of	Exercise		Remaining Contractual	Aggregate		Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Price		Term (years)	Intrinsic Value		Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2021	5,906,884	$	1.61
Granted	750,000		6.76
Outstanding at January 1, 2023							6,690,490	$	3.09
Granted*							25,000		3.31
Exercised	(1,546,288)		2.01				(148,167)		2.31
Forfeited/Expired	(20,000)		1.38				(64,666)		6.96
Outstanding at September 30, 2021	5,090,596	$	2.05	7.49	$	37,037,015
Outstanding at March 31, 2023							6,502,657	$	3.07	6.94	$	35,414,546

Exercisable at September 30, 2021	3,468,912	$	1.73	7.03	$	27,069,483
Exercisable at March 31, 2023							4,041,942	$	2.03	5.87	$	26,301,295

Vested and Expected to Vest at September 30, 2021	5,090,596	$	2.05	7.49	$	37,037,015
Vested and Expected to Vest at March 31, 2023							6,502,657	$	3.07	6.94	$	35,414,546

*On January 23, 2023 25,000 stock options were issued to a non-employee member of the Company’s advisory board. The stock options vest in 12 monthly installments commencing in June 2023.


				Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2022	5,536,896	$	2.66
Granted*	1,479,558		5.21
Exercised	(22,500)		1.17
Forfeited/Expired	(35,400)		5.10
Outstanding at March 31, 2022	6,958,554	$	3.20	7.84	$	26,515,544

Exercisable at March 31, 2022	3,418,917	$	1.82	6.53	$	17,679,562

Vested and Expected to Vest at March 31, 2022	6,958,554	$	3.20	7.84	$	26,515,544

*Includes 110,000 stock options granted by the Company to a non-employee director of the Company during the three-month period ended March 31, 2022. The stock option fully vests on January 1, 2025.

1416

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

Weighted-Average


Number of

Weighted - Average

Remaining Contractual

Aggregate

Options

Exercise Price

Term (years)

Intrinsic Value
Outstanding at January 1, 2022

5,536,896

$
2.66





Granted*

1,479,558

5.21




Exercised

(210,429)

1.28




Forfeited/Expired

(261,101)

6.50




Outstanding at September 30, 2022

6,544,924

$
3.13

7.33

$
6,265,207

Exercisable at September 30, 2022

4,264,408

$
2.08

6.40

$
5,792,971

Vested and Expected to Vest at September 30, 2022

6,544,924

$
3.13

7.33

$
6,265,207

*Includes ~~110,000~~ ~~stock options granted by the Company to a non-employee director of the Company during the nine months ended September 30, 2022. The stock option fully vests on January 1, 2025.~~

A summary of option activity under the Innodata Inc. 2021 Equity Compensation Plan, as amended and restated effective as of April 11, 2022 (the “2021 Plan”) and changes during the ~~nine-month period~~three-month periods ended ~~September 30, 2022~~March 31, 2023 are presented ~~below:~~below. There were no outstanding options under the 2021 Plan as of March 31, 2022.


				Weighted-Average						Weighted-Average
	Number of	Weighted - Average		Remaining Contractual	Aggregate Intrinsic		Number of	Weighted - Average		Remaining Contractual	Aggregate
	Options	Exercise Price		Term (years)	Value		Options	Exercise Price		Term (years)	Intrinsic Value
Outstanding at January 1, 2022	-	$	-
Granted*	182,000		3.67
Outstanding at January 1, 2023							1,027,500	$	3.46
Granted							-		-
Exercised	-		-				-		-
Forfeited/Expired	-		-				(33,500)		3.41
Outstanding at September 30, 2022	182,000	$	3.67	9.91	$	-
Outstanding at March 31, 2023							994,000	$	3.46	9.51	$	5,051,370

Exercisable at September 30, 2022	6,250	$	6.40
Exercisable at March 31, 2023							31,250	$	5.20	9.29	$	104,500

Vested and Expected to Vest at September 30, 2022	182,000	$	3.67	9.91	$	-
Vested and Expected to Vest at March 31, 2023							994,000	$	3.46	9.51	$	5,051,370

*During the ~~nine~~three months ended ~~September 30, 2022, the Company granted~~ ~~132,000~~ ~~stock options to non-employee directors of the Company which vest on the first anniversary of the date of grant. In addition, during the nine months ended September 30, 2022 the Company granted~~ ~~50,000~~ ~~stock options to non-employee members of the Company’s advisory board in lieu of cash compensation. The stock options vest in 12 monthly installments from the date of grant.~~

~~During the nine months ended September 30, 2022,~~March 31, 2023, a total of ~~210,429~~148,167 options were exercised at an average price of ~~$1.28.~~$2.31.

The fair value of stock options is estimated on the date of grant using the Black-Scholes option pricing model. The weighted-average fair value of the options granted, and weighted-average assumptions were as follows:


	For the Nine Months Ended September 30,				For the Three Months Ended March 31,
	2022		2021		2023			2022
Weighted average fair value of options granted	$	3.00	$	3.56	$	1.79		$	3.10
Risk-free interest rate		1.94%-3.54%		0.22%-0.82%		3.88	%		1.94%-2.33	%
Expected term (years)		3.0-6.42		3-6		3.0			6.0-6.42
Expected volatility factor		62% -79%		58% - 68%		79.95	%		62.00	%
Expected dividends		-		-		-			-

~~A summary~~There were no outstanding awards of restricted stock ~~units issued~~ under the 2013 Plan ~~and~~or the 2021 Plan (collectively, the “Equity Plans”) ~~is presented below:~~

~~Table~~during each of ~~Contents~~the three-month periods ended March 31, 2023 and 2022.

~~INNODATA INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

~~(Unaudited)~~

In March 2022, the Company granted restricted stock units (“RSU”) to key executives, pursuant to the Equity Plans. Each RSU has vesting conditions based on both the achievement of performance-based metrics and the continuation of employment over a defined period. The level of performance determines the number of RSUs that performance-vest, and performance vested RSUs must also time-vest in order to be fully vested. Each fully vested RSU represents the right to receive one share of the Company’s common stock or the fair market value of one share of common stock, at the Company’s discretion, and is classified as an equity award. Each RSU vests pursuant to the vesting schedule found in the respective RSU agreement. RSUs are generally subject to graduated vesting schedules and stock-based compensation expense is computed by tranche and recognized on a straight-line basis over the tranches’ applicable vesting period based on the expected achievement level. The fair value of restricted stock units is estimated on the date of grant using the Binomial option pricing model.

~~Restricted stock unit activity during the nine months ended September 30, 2022 was as follows:~~

Number of Restricted

Weighted-Average Grant

Stock Awards

Date Fair Value
Unvested at January 1, 2022

25,000

$
1.38
Granted

-

-
Vested

(25,000)

1.38
Forfeited/Expired

-

-
Unvested at September 30, 2022

-

$
-

Number of

Weighted-Average

Restricted Stock

Grant Date

Units

Fair Value
Unvested at January 1, 2022

-

$
-
Granted*

700,000

5.59
Vested

-

-
Forfeited/Expired

-

Unvested at September 30, 2022

700,000

$
5.59

* ~~200,000~~ ~~RSUs were issued under the 2013 Plan and~~ ~~500,000~~ ~~RSUs were issued under the 2021 Plan~~

The compensation cost related to non-vested stock options not yet recognized as of September 30, 2022 totaled approximately $5.9 million. The weighted-average period over which these costs will be recognized is 24 months.

During the nine months ended September 30, 2022, 700,000 performance-based restricted stock units were granted and remain non-vested at September 30, 2022. Vesting of the performance-based restricted stock units is contingent on the achievement of certain financial performance goals and service vesting conditions. There were no restricted stock units granted during the three months ended September 30, 2022.

The compensation cost related to non-vested restricted stock units not yet recognized as of September 30, 2022 totaled approximately $2.8 million. The weighted-average period over which these costs will be recognized is 22 months.

~~The stock-based compensation expense related to the Equity Plans were allocated as follows (in thousands):~~

For the Three Months Ended

For the Nine Months Ended

September 30,

September 30,


2022

2021

2022

2021
Direct operating costs

$
46

$
21

$
154

$
96
Selling and administrative expenses

759

482

2,216

1,021
Total stock-based compensation

$
805

$
503

$
2,370

$
1,117

1617

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

~~Subsequent Event~~

On October 7, 2022, the Company granted 1,143,000 stock options to Company’s executive officers and certain employees. 295,000 stock options were granted pursuant to the 2013 Plan and 848,000 stock options were granted pursuant to the 2021 Plan. The stock options have an exercise price of $3.41, a term of ten years from the date of grant, vest in three equal annual installments from the date of grant and have a grant date fair value of approximately $2.5 million.

~~6. Operating Leases~~

~~The Company has various lease agreements for its offices and service delivery centers. These lease agreements are for terms ranging from~~ ~~two~~ ~~to eleven years and, in most cases, provide for rental escalations ranging from 1.75% to 10%, The Company has determined that~~Restricted stock unit activity under the ~~risks and benefits related to these leased properties are retained by the lessors. Accordingly, these are accounted for as operating leases.~~

~~Lease Agreements with a term of less than one year are treated as short-term leases and accounted for separately as shown in table below.~~

~~Most of these lease agreements are renewable at the mutual consent~~Equity Plans during each of the ~~parties to the agreement.~~

~~The table below summarizes the amounts recognized in the condensed consolidated financial statements related to operating leases~~three-month periods ended March 31, 2023 and ~~short-term leases for the periods~~2022 are presented ~~(in thousands):~~below:


	For the Three Months Ended				For the Nine Months Ended				Number of	Weighted-Average
	September 30,				September 30,				Restricted Stock	Grant Date
	2022		2021		2022		2021		Units	Fair Value
Rent expense for long-term operating leases	$	314	$	393	$	1,027	$	1,169
Rent expense for short-term leases		136		59		398		143
Total rent expense	$	450	$	452	$	1,425	$	1,312
Unvested at January 1, 2023									700,000	$	5.59
Granted									-		-
Vested									-		-
Forfeited/Expired									-		-
Unvested at March 31, 2023									700,000	$	5.59


	Number of	Weighted-Average
	Restricted Stock	Grant Date
	Units	Fair Value
Unvested at January 1, 2022	-	$	-
Granted*	700,000		5.59
Vested	-		-
Forfeited/Expired	-		-
Unvested at March 31, 2022	700,000	$	5.59

* 200,000 RSUs were issued under the 2013 Plan and 500,000 RSUs were issued under the 2021 Plan.

The ~~following table presents~~compensation cost related to non-vested stock options not yet recognized as of March 31, 2023 totaled approximately $6.2 million. The weighted-average period over which these costs will be recognized is 23 months.

During the ~~maturity profile~~fiscal year ended December 31, 2022, 700,000 performance-based restricted stock units were granted and remain unvested at March 31, 2023. Vesting of the ~~Company’s operating lease liabilities based~~performance-based restricted stock units is contingent on the ~~contractual undiscounted payments with a reconciliation~~achievement of certain financial performance goals and service vesting conditions. There were no restricted stock units granted during the three months ended March 31, 2023.

The compensation cost related to non-vested restricted stock units not yet recognized as of March 31, 2023 totaled approximately $2.8 million. The weighted-average period over which these ~~amounts~~costs will be recognized is 24 months.

The stock-based compensation expense related to the ~~remaining net present value of the operating lease liability reported in the condensed consolidated balance sheet~~Equity Plans were allocated as ~~of September 30, 2022~~follows (in thousands):

Year

Amount
2022

$
283
2023

1,030
2024

825
2025

837
2026

847
2027 and thereafter

2,384
Total lease payments

6,206
Less: Interest

(1,534)
Net present value of lease liabilities

$
4,672

Current portion

$
742
Long-term portion

3,930
Total

$
4,672


	For the Three Months Ended
	March 31,
	2023		2022
Direct operating costs	$	63	$	52
Selling and administrative expenses		899		485
Total stock-based compensation	$	962	$	537

1718

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

~~The weighted average remaining lease terms and discount rates for all the Company’s operating leases as of September 30, 2022 were as follows:~~


~~Weighted-average lease term remaining~~	~~55 months~~
~~Weighted-average discount rate~~	~~8.55~~	%

~~7. Long-term obligations~~

~~Total long-term obligations as of September 30, 2022 and December 31, 2021 consisted of the following (in thousands):~~

September 30,

December 31,

2022

2021
Pension obligations - accrued pension liability

$
6,376

$
6,839
Settlement agreement

94

272
Microsoft licenses

-

385

6,470

7,496
Less: Current portion of long-term obligations

596

1,279
Totals

$
5,874

$
6,217

8.10. Redemption of non-controlling interest

The Condensed Consolidated Balance Sheets for the ~~nine-month~~fiscal period ~~ending September 30,~~ended December 31, 2022 includes a $2.9 million charge against additional paid-in-capital representing the carrying value of the non-controlling interest in Innodata Synodex, LLC which was redeemed by the Company on March 31, 2022. The Company accounted for the transaction in accordance with ASC Topic 810, “Consolidation,” which discusses the proper accounting treatment of the carrying value for the non-controlling interest. Under the standard, any change in ownership that does not result in a loss of control must be accounted for as an equity transaction.

9.11. Comprehensive loss

Accumulated other comprehensive loss, as reflected in the condensed consolidated balance sheets, consists of pension liability adjustments, net of taxes, foreign currency translation adjustment and changes in fair value of derivatives, net of ~~taxes, and foreign currency translation adjustment.~~taxes. The components of accumulated other comprehensive loss as of ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ and reclassifications from accumulated other comprehensive loss for the three ~~and nine~~ months then ended, are presented below (in thousands):


	Pension Liability		Fair Value of		Foreign Currency		Accumulated Other		Pension Liability		Fair Value of		Foreign Currency		Accumulated Other
	Adjustment		Derivatives		Translation Adjustment		Comprehensive Loss		Adjustment		Derivatives		Translation Adjustment		Comprehensive Loss
Balance at July 1, 2022	$	(780)	$	(889)	$	(1,607)	$	(3,276)
Balance at January 1, 2023									$	(86)	$	(365)	$	(1,657)	$	(2,108)
Other comprehensive loss before reclassifications, net of taxes		-		(884)		(644)		(1,528)		-		242		60		302
Total other comprehensive loss before reclassifications, net of taxes		(780)		(1,773)		(2,251)		(4,804)		(86)		(123)		(1,597)		(1,806)
Net amount reclassified to earnings		35		678		-		713		(5)		181		-		176
Balance at September 30, 2022	$	(745)	$	(1,095)	$	(2,251)	$	(4,091)
Balance at March 31, 2023									$	(91)	$	58	$	(1,597)	$	(1,630)


					Foreign Currency
	Pension Liability		Fair Value of		Translation		Accumulated Other
	Adjustment		Derivatives		Adjustment		Comprehensive Loss
Balance at January 1, 2022	$	(858)	$	(353)	$	(981)	$	(2,192)
Other comprehensive loss before reclassifications, net of taxes		-		(78)		(26)		(104)
Total other comprehensive loss before reclassifications, net of taxes		(858)		(431)		(1,007)		(2,296)
Net amount reclassified to earnings		40		83		-		123
Balance at March 31, 2022	$	(818)	$	(348)	$	(1,007)	$	(2,173)

Taxes related to each component of other comprehensive loss were not material for each of the three-month periods presented and therefore not disclosed separately.

All reclassifications from accumulated other comprehensive loss had an impact on direct operating costs in the condensed consolidated statements of operations and comprehensive loss.

1819

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE~~(Unaudited)

12. Segment reporting and concentrations

The Company’s operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility.

The DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. The DDS segment also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

The Synodex segment provides an industry platform that transforms medical records into useable digital data organized in accordance with its proprietary data models or customer data models.

The Agility segment provides an industry platform that provides marketing communications and public relations professionals with the ability to target and distribute content to journalists and social media influencers world-wide and to monitor and analyze global news channels (print, web, radio and TV) and social media channels.

A significant portion of the Company’s revenue is generated from its locations in the Philippines, India, Sri Lanka, Canada, Germany, the United Kingdom and Israel.

Revenues from external customers, segment operating profit (loss), and other reportable segment information are as follows (in thousands):


	For the Three Months Ended March 31,
	2023		2022
Revenues:
DDS	$	12,746	$	15,911
Synodex		1,865		1,669
Agility		4,228		3,612
Total Consolidated	$	18,839	$	21,192

Income (loss) before provision for income taxes⁽¹⁾:
DDS	$	(281)	$	1,452
Synodex		(111)		(988)
Agility		(1,503)		(2,879)
Total Consolidated	$	(1,895)	$	(2,415)

Income (loss) before provision for income taxes⁽²⁾:
DDS	$	(423)	$	1,296
Synodex		14		(859)
Agility		(1,486)		(2,852)
Total Consolidated	$	(1,895)	$	(2,415)

Table of Contents

INNODATA INC. AND ~~NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Foreign Currency


Pension Liability

Fair Value of

Translation

Accumulated Other

Adjustment

Derivatives

Adjustment

Comprehensive Loss
Balance at January 1, 2022

$
(858)

$
(353)

$
(981)

$
(2,192)
Other comprehensive loss before reclassifications, net of taxes

-

(1,707)

(1,270)

(2,977)
Total other comprehensive loss before reclassifications, net of taxes

(858)

(2,060)

(2,251)

(5,169)
Net amount reclassified to earnings

113

965

-

1,078
Balance at September 30, 2022

$
(745)

$
(1,095)

$
(2,251)

$
(4,091)


	March 31, 2023		December 31, 2022
Total assets:
DDS	$	26,251	$	25,758
Synodex		3,433		3,270
Agility		19,451		19,014
Total Consolidated	$	49,135	$	48,042

Pension Liability

Fair Value of

Foreign Currency

Accumulated Other


Adjustment

Derivatives

Translation Adjustment

Comprehensive Loss

Balance at July 1, 2021

$
(422)

$
(267)

$
(380)

$
(1,069)
Other comprehensive income (loss) before reclassifications, net of taxes

-

(302)

(594)

(896)
Total other comprehensive loss before reclassifications, net of taxes

(422)

(569)

(974)

(1,965)
Net amount reclassified to earnings

10

37

-

47
Balance at September 30, 2021

$
(412)

$
(532)

$
(974)

$
(1,918)

Foreign Currency

Pension Liability

Fair Value of

Translation

Accumulated Other


Adjustment

Derivatives

Adjustment

Comprehensive Loss
Balance at January 1, 2021

$
(444)

$
-

$
(494)

$
(938)
Other comprehensive income (loss) before reclassifications, net of taxes

-

(536)

(480)

(1,016)
Total other comprehensive loss before reclassifications, net of taxes

(444)

(536)

(974)

(1,954)
Net amount reclassified to earnings

32

4

-

36
Balance at September 30, 2021

$
(412)

$
(532)

$
(974)

$
(1,918)

~~All reclassifications from accumulated other comprehensive loss had an impact on direct operating costs in the condensed consolidated statements of operations and comprehensive income (loss).~~

~~10. Segment reporting and concentrations~~

~~The Company’s operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility.~~

The DDS segment provides AI-enabled software platforms and managed services to companies that require high-quality data for training AI and machine learning (ML) algorithms, and AI digital transformation solutions to help companies apply AI/ML to real-world problems relating to analyzing and deriving insights from documents. In conjunction with AI digital transformation, the Company often provides a range of data engineering support services, including data transformation, data curation, data hygiene, data consolidation, data compliance, and master data management.

~~The Synodex segment provides an industry platform that transforms medical records into useable digital data organized in accordance with its proprietary data models or customer data models.~~

~~Table of Contents~~

~~INNODATA INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

~~(Unaudited)~~

~~A significant portion of the Company’s revenue is generated from its locations in the Philippines, India, Sri Lanka, Canada, Germany, the United Kingdom and Israel.~~

~~Revenues from external customers, segment operating profit (loss), and other reportable segment information are as follows (in thousands):~~

For the Three Months Ended September 30,

For the Nine Months Ended September 30,


2022

2021

2022

2021
Revenues:








DDS

$
12,852

$
13,237

$
42,944

$
37,997
Synodex

1,762

983

5,376

2,888
Agility

3,833

3,230

11,306

9,581
Total Consolidated

$
18,447

$
17,450

$
59,626

$
50,466

Income (loss) before provision for income taxes⁽¹⁾:

DDS

$
135

$
1,544

$
1,516

$
3,924
Synodex

(977)

(657)

(2,796)

(878)
Agility

(2,216)

(1,406)

(7,474)

(2,993)
Total Consolidated

$
(3,058)

$
(519)

$
(8,754)

$
53

Income (loss) before provision for income taxes⁽²⁾:

DDS

$
(59)

$
1,445

$
987

$
3,676
Synodex

(778)

(584)

(2,318)

(711)
Agility

(2,221)

(1,380)

(7,423)

(2,912)
Total Consolidated

$
(3,058)

$
(519)

$
(8,754)

$
53

September 30, 2022

December 31, 2021
Total assets:




DDS

$
26,542

$
38,180
Synodex

3,294

1,753
Agility

17,973

19,284
Total Consolidated

$
47,809

$
59,217


	September 30, 2022		December 31, 2021		March 31, 2023		December 31, 2022
Goodwill:
Agility	$	1,982	$	2,143	$	2,044	$	2,038
Total	$	1,982	$	2,143	$	2,044	$	2,038

(1)	Before elimination of any inter-segment profits

(2)	After elimination of any inter-segment profits

The table below shows intersegment revenues which are eliminated in consolidation (in thousands).

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2022

2021

2022

2021
Revenues of DDS Segment from:








Synodex

2,119

1,113

6,167

2,559
Agility

425

411

1,274

1,229
Totals

2,544

1,524

7,441

3,788


	For the Three Months Ended March 31,
	2023		2022
Revenues of DDS Segment from:
Synodex	$	447	$	564
Agility		32		33
Totals	$	479	$	597

Revenues for the period ended March 31, 2023 and 2022 by geographic region (determined based upon customer’s domicile), were as follows (in thousands):


	March 31,
	2023		2022
United States	$	11,409	$	13,393
United Kingdom		2,555		3,082
The Netherlands		1,723		1,652
Canada		1,438		1,377
Others - principally Europe		1,714		1,688
Totals	$	18,839	$	21,192

2021

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

~~(Unaudited)~~

~~Revenues for the period ended September 30, 2022 and 2021 by geographic region (determined based upon customer’s domicile), were as follows (in thousands):~~

For the Three Months Ended

For the Nine Months Ended

September 30,

September 30,


2022

2021

2022

2021
United States

$
11,904

$
9,467

$
37,843

$
26,761
United Kingdom

2,677

2,912

8,312

8,709
The Netherlands

1,734

1,750

5,105

5,012
Canada

579

1,469

3,234

4,556
Others - principally Europe

1,553

1,852

5,132

5,428
Totals

$
18,447

$
17,450

$
59,626

$
50,466

~~Long-lived assets as of September 30, 2022 and December 31, 2021 by geographic region were comprised of (in thousands):~~

September 30,

December 31,

2022

2021
United States

$
6,747

$
4,578

Foreign countries:

Canada

7,669

9,280
United Kingdom

1,139

1,538
Philippines

3,784

4,027
India

1,364

1,481
Sri Lanka

136

154
Israel

2

-
Total foreign

14,094

16,480
Totals

$
20,841

$
21,058

~~Long-lived assets include the unamortized balance of right-of-use assets amounting to $4.2 million and $5.6 million as of September 30, 2022 and December 31, 2021, respectively.~~

No customer generated 10% or more of the Company’s total revenues for the three months ended September 30, 2022. One customer in the DDS segment generated approximately 10% of the Company’s total revenues for the three months ended September 30, 2021. Further, revenues from non-U.S. customers accounted for 35% and 46% of the Company’s total revenues for the three months ended September 30, 2022 and 2021, respectively.

One customer in the DDS segment generated approximately 13% and 11% of the Company’s total revenues for the nine months ended September 30, 2022 and 2021, respectively. No other customer accounted for 10% or more of total revenues during these periods. Further, revenues from non-U.S. customers accounted for 37% and 47% of the Company’s total revenues for the nine months ended September 30, 2022 and 2021, respectively.

As of September 30, 2022, approximately 47% of the Company’s accounts receivable was from foreign (principally European) customers and 24% of the Company’s accounts receivable was due from two customers. As of December 31, 2021, approximately 37% of the Company’s accounts receivable was from foreign (principally European) customers and 19% of the Company’s accounts receivable was due from one customer. No other customer accounted for 10% or more of the accounts receivable as of September 30, 2022 and December 31, 2021.

~~Table of Contents~~

~~INNODATA INC. AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS~~

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

~~11. Income (Loss) Per Share~~Long-lived assets as of March 31, 2023 and December 31, 2022 by geographic region were comprised of (in thousands):


	For the Three Months Ended				For the Nine Months Ended				March 31,		December 31,
	September 30,				September 30,				2023		2022
United States									$	7,944	$	7,205
	2022		2021		2022		2021
Net Loss attributable to Innodata Inc. and Subsidiaries	$	(3,327)	$	(800)	$	(9,975)	$	(505)
Weighted average common shares outstanding		27,331		26,971		27,239		26,459
Dilutive effect of outstanding options		-		-		-		-
Adjusted for dilutive computation		27,331		26,971		27,239		26,459
Foreign countries:
Canada										7,633		7,675
United Kingdom										1,160		1,198
Philippines										3,631		3,682
India										991		1,195
Sri Lanka										446		426
Israel										2		3
Germany										-		-
Total foreign										13,863		14,179
Totals									$	21,807	$	21,384

Long-lived assets include the unamortized balance of right-of-use assets amounting to $4.1 million and $4.3 million as of March 31, 2023 and December 31, 2022, respectively.

One customer in the DDS segment generated approximately 11% and another customer in the DDS segment generated 11% of the Company’s total revenues for the three months ended March 31, 2023. Another customer in the DDS segment generated approximately 21% of the Company’s total revenues for the three months ended March 31, 2022. No other customer accounted for 10% or more of total revenues during these periods. Further, for the three months ended March 31, 2023 and 2022, revenues from non-U.S. customers accounted for 39% and 37%, respectively, of the Company’s total revenues.

As of March 31, 2023, approximately 38% of the Company’s accounts receivable was due from foreign (principally European) customers and 30% of the Company’s accounts receivable was due from two customers. As of December 31, 2022, approximately 44% of the Company’s accounts receivable was due from foreign (principally European) customers and 45% of the Company’s accounts receivable was due from four customers. No other customer accounted for 10% or more of the accounts receivable as of March 31, 2023 and December 31, 2022.

13. Loss Per Share


	For the Three Months Ended
	March 31,
	2023		2022
Net Loss attributable to Innodata Inc. and Subsidiaries	$	2,116	$	2,815
Weighted average common shares outstanding		27,460		27,158
Dilutive effect of outstanding options		-		-
Adjusted for dilutive computation		27,460		27,158

Basic income (loss) per share is computed using the weighted-average number of common shares outstanding during the year. Diluted income (loss) per share is computed by considering the impact of the potential issuance of common shares, using the treasury stock method, on the weighted-average number of shares outstanding. For those securities that are not convertible into a class of common stock, the “two-class” method of computing income (loss) per share is used.

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Options to purchase ~~4.2~~6.6 million and ~~5.1~~7.0 million shares of common stock for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021 were outstanding but not included in the computation of diluted loss per share because the effect would have been anti-dilutive.~~

~~Options to purchase 5.7 and 5.1 million shares of common stock for the nine months ended September 30, 2022 and 2021~~respectively, were outstanding but not included in the computation of diluted loss per share because the effect would have been anti-dilutive.

~~12.~~14. Derivatives

The Company conducts a large portion of its operations in international markets, which ~~subject~~subjects it to foreign currency fluctuations. The most significant foreign currency exposures occur when revenue and associated accounts receivable are collected in one currency and expenses to generate that revenue are incurred in another currency. The Company is also subject to wage inflation and other government mandated increases and operating expenses in Asian countries where the Company has the majority of its operations. The Company’s primary inflation and exchange rate exposure relates to payroll, other payroll costs and operating expenses in the Philippines, India, Sri Lanka and Israel.

In addition, although most of the Company’s revenue is denominated in U.S. dollars, a significant portion of total revenues is denominated in Canadian dollars, Pound Sterling and Euros.

The Company’s policy is to enter derivative instrument contracts with terms that coincide with the underlying exposure being hedged for a period of up to 12 months. As such, the Company’s derivative instruments are expected to be highly effective. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded to Other comprehensive income (loss). Upon settlement of these contracts, the change in the fair value recorded in Other comprehensive income (loss) are reclassified to earnings and included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking hedge transactions. The Company does not hold or issue derivatives for trading purposes. All derivatives are recognized at their fair value and classified based on the instrument’s maturity date. The total notional amount for outstanding derivatives designated as hedges was ~~$14.4~~$9.8 million and $14.2 million as of ~~September 30, 2022.~~ March 31, 2023 and December 31, 2022, respectively.

The ~~total notional amount for outstanding derivatives designated as hedges was $19.7 million~~following table presents the fair value of derivative instruments included within the condensed consolidated balance sheets as of March 31, 2023 and December 31, ~~2021.~~2022 (in thousands):


	Balance Sheet Location	Fair Value
		2023		2022
Derivatives designated as hedging instruments:

Foreign currency forward contracts	Prepaid expenses and other current assets	$	58	$	-

Foreign currency forward contracts	Accrued expenses and other	$	-	$	365

2223

Table of Contents

INNODATA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021~~

(Unaudited)

~~The following table presents the fair value of derivative instruments included within the condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021 (in thousands):~~

Balance Sheet Location

Fair Value




2022

2021
Derivatives designated as hedging instruments:







Foreign currency forward contracts

Accrued expenses

$
1,095

$
353

The effect of foreign currency forward contracts designated as cash flow hedges on the condensed consolidated statements of operations for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ were as follows (in thousands):


	For the Three Months Ended				For the Nine Months Ended				For the Three Months Ended
	September 30,				September 30,				March 31,
	2022		2021		2022		2021		2023		2022
Net gain (loss) recognized in OCI⁽¹⁾	$	(884)	$	(302)	$	(1,707)	$	(536)	$	242	$	(78)
Net (gain) loss reclassified from accumulated OCI into income⁽²⁾	$	678	$	37	$	965	$	4	$	181	$	83
Net gain recognized in income⁽³⁾		-	$	-		-	$	-	$	-	$	-

(1)	Net change in fair value of the effective portion classified into other comprehensive income (“OCI”)

(2)	Effective portion classified within direct operating costs.

(3)	There were no ineffective portions for the period presented.

15. Subsequent Event

On April 4, 2023, Innodata Inc. entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as lender, Innodata Synodex, LLC, Innodata docGenix, LLC, and Agility PR Solutions LLC. The Credit Agreement provides for a secured revolving line of credit (the “Revolving Credit Facility”) up to an amount equal to the lesser of the borrowing base and $10.0 million with a maturity date of April 4, 2026. The Revolving Credit Facility’s borrowing base is calculated in accordance with the terms of the Credit Agreement and on the basis of 85% of eligible accounts, 85% of eligible foreign accounts up to $2.0 million and certain other reserves and adjustments. The Credit Agreement contains a financial covenant that will require the Borrowers, on a consolidated basis, to maintain a fixed charge coverage ratio of not less than 1.10 to 1.00 by December 31, 2023. Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to the daily simple secured overnight financing rate (“SOFR”) plus 2.25%.

2324

Table of Contents

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

Cautionary Note Regarding Forward-Looking Statements

Disclosures in this Quarterly Report on Form 10-Q (this “Report”) contain certain forward-looking statementswithin the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These forward-looking statements include, without limitation, statements concerning our operations, economic performance, and financial condition. Words such as “project,” “believe,” “expect,” “can,” “continue,” “could,” “intend,” “may,” “should,” “will,” “anticipate,” “indicate,” “predict,” “likely,” “estimate,” “plan,” “potential,~~” “supports,~~” or the negatives thereof, and other similar expressions generally identify forward-looking statements.

These forward-looking statements are based on management’s current expectations, assumptions and estimates and are subject to a number of risks and uncertainties, including, without limitation, the expected or potential effects of the novel coronavirus (“COVID-19”) pandemic and the responses of governments, the general global population, our customers, and the Company thereto; impacts resulting from the rapidly evolving conflict between Russia and the Ukraine; that contracts may be terminated by customers; projected or committed volumes of work may not materialize; pipeline opportunities and customer discussions which may not materialize into work or expected volumes of work; continuing reliance on project-based work in the DDS segment and the primarily at-will nature of such contracts and the ability of these customers to reduce, delay or cancel projects; the likelihood of continued development of the markets, particularly new and emerging markets, that our services support; continuing DDS segment revenue concentration in a limited number of customers; potential inability to replace projects that are completed, canceled or reduced; our dependency on content providers in our Agility segment; difficulty in integrating and deriving synergies from acquisitions, joint venture and strategic investments; potential undiscovered liabilities of companies and businesses that we may acquire; potential impairment of the carrying value of goodwill and other acquired intangible assets of companies and businesses that we acquire; a continued downturn in or depressed market conditions, whether as a result of the COVID-19 pandemic or otherwise; changes in external market factors; the ability and willingness of our customers and prospective customers to execute business plans that give rise to requirements for our services; changes in our business or growth strategy; the emergence of new, or growth in existing competitors; various other competitive and technological factors; the Company’s use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, or service interruptions; and other risks and uncertainties indicated from time to time inon our filings with the Securities and Exchange Commission.

Our actual results could differ materially from the results referred to in forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, ~~uncertainty around the COVID-19 pandemic and the effects of the global response thereto and~~ the risks discussed in Part I, Item 1A. “Risk ~~Factors,” in~~Factors”, “Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and other parts of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on ~~March~~February 24, ~~2022,~~2023 and in our other filings that we may make with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements will occur, and you should not place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date hereof.

We undertake no obligation to update or review any guidance or other forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by the federal securities laws.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the results of operations and financial condition of Innodata Inc. and its subsidiaries and should be read in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes to condensed consolidated financial statements contained in Part I, Item 1 of this Report.

Table of Contents

Business Overview

Innodata Inc. (NASDAQ: INOD) (including its subsidiaries, the “Company”, “Innodata”, “we”, “us” or “our”) is a ~~global~~leading data engineering company. ~~The Company’s~~Our mission is to help the world’s most prestigious companies deliver the promise of AIethical, high-performing artificial intelligence (“AI”), which we believe will contribute to a safer and more prosperous world.

Innodata was founded on a simple idea: engineer the highest quality data so organizations across broad industry segments could make smarter decisions. Today, we believe we’re delivering the highest quality data for some of the world’s most ~~prestigious companies.~~innovative technology companies to use to train the AI models of the future.

~~We provide AI-enabled software platforms~~AI holds the promise that computers can perceive and managed service to companies that require high-quality data for training AI and machine learning (ML) algorithms. We also provide AI digital transformation solutions and platform to help companies apply AI/ML to real-world problems relating to analyzing and deriving insights from documents. For industry-specific, document-intensive industry business processes, we provide AI-augmented software-as-a-service (SaaS) platforms and discrete managed services.

~~Table of Contents~~

~~Our platforms~~understand the world, enabling products and services that would have been previously unimaginable and impossible with traditional coding. AI learns from data, and the highest-performing AI will have learned from the highest-quality data. We believe that we can contribute meaningfully by harnessing our capabilities, honed over 30 years, in collecting and annotating data at scale with consistency and high accuracy.

We are ~~powered by Goldengate,~~also helping companies deploy and integrate AI into their operations and products and providing innovative AI-enabled industry platforms, helping ensure that our ~~proprietary AI/ML platform, as well as other technologies we have developed. In addition, we bring to bear more than 4,500 employees spanning eight countries with expertise~~customers’ businesses are prepared for a world in ~~data pertaining to many professional fields. Our hybrid approach of using AI/ML~~which machines augment human activity in ~~conjunction with human experts enables us to deliver superior data quality with even the most complex and sensitive data.~~ways previously unimaginable.

We developed our capabilities and honed our ~~customer- and quality-centric culture~~approaches progressively over the last 30 years creating high-quality data for many of the world’s most demanding information companies. Approximately ~~six~~seven years ago, we formed Innodata Labs, a research and development center, to research, develop and apply machine learning and emerging AI to our large-scale, human-intensive data operations. In 2019, we began packaging the capabilities that emerged from our R&D efforts in order to align with several fast-growing new markets and help companies use AI/ML to drive performance benefits and business insights. ~~We anticipate this strategy will enable us to accelerate growth.~~

Our historical core competency in high-quality data, combined with these R&D efforts in applied AI, created the foundation for the evolution of our offerings, which include AI Data Preparation, AI Model Deployment and Integration, and AI-Enabled Industry Platforms.

AI Data ~~Annotation~~Preparation

We collect or create training data, annotate training data, and train AI algorithms for social media companies, robotics companies, financial services companies, and many others, working with images, text, video and audio. Data sciences teams seek partners that can perform data preparation functions for them at large-scale and at high quality, while using automated tools to minimize cost. Moreover, as AI projects become more specialized and mission-critical, data preparation is becoming increasingly complex, requiring deep domain knowledge and an infrastructure in which data security is assured.

We utilize a variety of leading third-party image and video annotation tools. For text, we use our proprietary ~~text~~data annotation platform that incorporates AI to reduce cost while improving consistency and quality of output. Our proprietary ~~text~~data annotation platform features auto-tagging capabilities that apply to both classical and generative AI tasks. ~~It also~~The platform encapsulates many of the innovations we conceived of in the course of our 30-year history of creating high-quality data.

In addition, because collecting real-world data is often impracticable (due to data privacy regulations or rarity of cohorts and outliers), we create high-quality synthetic data that maintains all of the statistical properties of real-world data, using a combination of domain specialists and machine technologies that leverage large language models (LLMs).

AI ~~Digital Transformation~~Model Deployment and Integration

We help businesses leverage the latest AI technologies to achieve their goals. We develop custom AI models (where we select the appropriate algorithms, tune hyperparameters, train and validate the models, and update the models as required). We also provide AI solutions and platforms to companies that intensively process textual data and seek to obtain the benefits of AI/ML technologies without having to develop AI/ML engineering capabilities in-house. For such companies, we often integrate one or morehelp businesses fine-tune their own custom versions of our ~~pre-trained text processing algorithms as a~~proprietary models and third-party foundation ~~for an overall solution. Our algorithms are accessible as microservices via application programming interfaces (APIs), enabling easy integration.~~models to address domain-specific and customer-specific use cases.

In ~~conjunction with~~addition to deploying and integrating AI ~~digital transformation,~~models, we often provide a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

Table of Contents

Our customers span a diverse range of industries and a wide range of AI use cases, benefiting from the short time-to-value and high economic returns of our AI ~~digital transformation~~ solutions and platforms.

AI-Enabled Industry AI Platforms

Our AI-enabled industry platforms address specific, niche market requirements ~~that~~ we believe we can ~~fulfill in large part~~innovate with ~~our~~ AI/ML technologies. We deploy these industry platforms as software-as-a-service (SaaS) and as managed services. These platforms benefit from our technology infrastructure, our industry-specific knowledge, our strong customer relationships and experience merging technology with the business processes of our customers. To date, we have built an industry platform for medical records data extraction and transformation (which we brand as ~~“Synodex®~~“Synodex^®”) and an industry platform for public relations (which ~~brands~~we brand as “Agility PR Solutions”). We are in the development with an additional AI-enabled industry platform to serve financial services institutions.

Our Synodex industry platform transforms medical records into useable digital data organized in accordance with our proprietary data models or customer data models.

Our Agility industry platform provides marketing communications and public relations professionals with the ability to target and distribute content to journalists and social media influencers world-wide and to monitor and analyze global news (print, web, radio and TV) and social media.

Our operations are presently classified and reported in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility.

Prevailing Economic Conditions and Seasonality

Prevailing Economic Conditions

~~Table of Contents~~

The novel coronavirus disease 2019, which the World Health Organization declared as a pandemic on March 11, 2020, continues to spread throughout the world. COVID-19 has created significant global economic downturn, disrupted global trade and supply chains, adversely impacted many industries, caused federal and regional governments to impose substantial restrictions on the operations of non-essential businesses and contributed to significant declines and volatility in financial markets.

While the pandemic presented, and may in the future present, new risks to our business and there have been logistical and other challenges, there was no material adverse impact on our results of operations for the three and nine months ended September 30, 2022.

The situation surrounding the COVID-19 crisis remains fluid and the extent and duration of its impact to the economy remains unclear. For this reason, we cannot reasonably estimate with any degree of certainty the future impact that it may have on our results of operations and financial condition. The potential for a material impact on our results of operations and financial position increases the longer COVID-19 affects the level of economic activity in the United States and globally.

With the current level of demand for our services, we believe we have existing cash and cash equivalents that provide sufficient sources of liquidity to satisfy our financial needs for at least the next 12 months from the date of the filing of this Report (refer to Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources” for additional information). In the event we experience a significant or prolonged reduction in revenues, the likelihood of which is uncertain, we would seek to manage our liquidity by utilizing the Revolving Credit Facility, reducing capital expenditures, deferring investment activities, and reducing operating ~~costs as we would likely have no other sources of liquidity to support ongoing operations in a manner that is not significantly detrimental to the business.~~costs.

Seasonality

Our quarterly operating results are subject to certain fluctuations. We experience fluctuations in our revenue and earnings as we replace and begin new projects, which may have some normal start-up delays, or we may be unable to replace a project entirely. These and other factors may contribute to fluctuations in our operating results from quarter to quarter. In addition, as some of our Asian facilities are closed during holidays in the fourth quarter, we typically incur higher wages, due to overtime, that reduce our margins.

Our Synodex subsidiary experiences seasonal fluctuations in revenues. Typically, revenue is lowest in the third quarter of the calendar year and highest in the fourth quarter of the calendar year. The seasonality is directly linked to the number of life insurance applications received by the insurance companies.

Trends

We view new customer acquisition as an indicator of our business momentum, sales and marketing efficiency, and competitive market positioning. During the ~~nine months~~three-month period ending ~~September 30, 2022,~~March 31, 2023, we added ~~an average of 113~~129 new ~~customers per quarter.~~customers. This is ~~an 82% increase over the 62 new customers we added on average per quarter in 2020 and~~ a ~~22%~~39% increase over the 93 new customers we added on average per quarter in ~~2021.~~2021 and a 3% increase over the 126 new customers we added on average per quarter in 2022.

For further information, refer to the risk factor titled “Quarterly fluctuations in our revenues and results of operations could make financial forecasting difficult and could ~~unfavorably~~negatively affect our stock price.” in Part I, Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022.

Table of Contents

Non-GAAP Financial Measures

In addition to the financial information prepared in conformity with U.S. GAAP (“GAAP”), we provide certain non-GAAP financial information. We believe that these non-GAAP financial measures assist investors in making comparisons of period-to-period operating results. In some respects, management believes non-GAAP financial measures are more indicative of our ongoing core operating performance than their GAAP equivalents by making adjustments that management believes are reflective of the ongoing performance of the business.

We believe that the presentation of this non-GAAP financial information provides investors with greater transparency by providing investors a more complete understanding of our financial performance, competitive position, and prospects for the future, particularly by providing the same information that management and our Board of Directors ~~uses~~use to evaluate our performance and manage the business. However, the non-GAAP financial measures presented in this Quarterly Report on Form 10-Q have certain limitations in that they do not reflect all of the costs associated with the operations of our business as determined in accordance with GAAP. Therefore, investors should consider non-GAAP financial measures in addition to, and not as a substitute for, or as superior to,

~~Table of Contents~~

measures of financial performance prepared in accordance with GAAP. Further, the non-GAAP financial measures that we present may differ from similar non-GAAP financial measures used by other companies.

Adjusted Gross Profit and Adjusted Gross Margin

We define Adjusted Gross Profit as revenues less direct operating costs attributable to Innodata Inc. and its subsidiaries in accordance with U.S. GAAP plus, depreciation and amortization of intangible assets, stock-based compensation, non-recurring severance and other one-time costs.

We define Adjusted Gross Margin by dividing Adjusted Gross Profit over total U.S. GAAP revenues.

We use Adjusted Gross Profit and Adjusted Gross Margin to evaluate results of operations and trends between fiscal periods and believe that these measures are important components of our internal performance measurement process.

The following table contains a reconciliation of Gross Profit and Gross Margin in accordance with the U.S. GAAP attributable to Innodata Inc. and its subsidiaries to Adjusted Gross Profit and Adjusted Gross Margin for the three months ended March 31, 2023 and 2022 (in thousands).


	Three Months Ended March 31,
Consolidated	2023		2022

Gross Profit attributable to Innodata Inc. and Subsidiaries	5,965		7,778
Depreciation and amortization	1,065		839
Severance**	327		-
Stock-based compensation	63		52
Adjusted Gross Profit	7,420		8,669

Gross Margin	32	%	37	%
Adjusted Gross Margin	39	%	41	%

Table of Contents


	Three Months Ended March 31,
DDS Segment	2023		2022

Gross Profit attributable to DDS Segment	4,159		6,554
Depreciation and amortization	200		190
Severance**	28		-
Stock-based compensation	51		44
Adjusted Gross Profit	4,438		6,788

Gross Margin	33	%	41	%
Adjusted Gross Margin	35	%	43	%


	Three Months Ended March 31,
Synodex Segment	2023		2022

Gross Profit/(Loss) attributable to Synodex Segment	203		(230)
Depreciation and amortization	162		41
Severance**	-		-
Stock-based compensation	-		-
Adjusted Gross Profit	365		(189)

Gross Margin	11	%	(14)	%
Adjusted Gross Margin	20	%	(11)	%


	Three Months Ended March 31,
Agility Segment	2023		2022

Gross Profit attributable to Agility Segment	1,603		1,454
Depreciation and amortization	703		608
Severance**	299		-
Stock-based compensation	12		8
Adjusted Gross Profit	2,617		2,070

Gross Margin	38	%	40	%
Adjusted Gross Margin	62	%	57	%

**Represents non-recurring severance incurred for a reduction in headcount in connection with the re-alignment of the Company’s cost structure.

Adjusted EBITDA

We define Adjusted EBITDA as net income (loss) attributable to Innodata Inc. and its subsidiaries in accordance with U.S. GAAP before interest expense, income taxes, depreciation and amortization of intangible assets (which derives EBITDA), plus additional adjustments for loss on impairment of intangible assets and goodwill, stock-based compensation, income (loss) attributable to non-controlling interests, non-recurring severance, and other one-time costs. We use Adjusted EBITDA to evaluate core results of operations and trends between fiscal periods and believe that these measures are important components of our internal performance measurement process.

The following table contains a reconciliation of U.S. GAAP net income (loss) attributable to Innodata Inc. and its subsidiaries to Adjusted EBITDA (loss) for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~ (in thousands).

Table of Contents


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
Consolidated	2022		2021		2022		2021		2023		2022
Net loss attributable to Innodata Inc. and Subsidiaries	$	(3,327)	$	(800)	$	(9,975)	$	(505)	$	(2,116)	$	(2,815)
Provision for income taxes		268		328		1,293		621		218		475
Interest expense, net		(1)		4		1		18		63		3
Gain on loan forgiveness		-		-		-		(580)
Depreciation and amortization		1,011		684		2,836		2,054		1,091		873
Severance**										580		-
Stock-based compensation		805		503		2,370		1,117		962		537
Non-controlling interests		1		(47)		(72)		(63)		3		(75)
Adjusted EBITDA / (loss) - Consolidated	$	(1,243)	$	672	$	(3,547)	$	2,662
Adjusted EBITDA / (loss)									$	801	$	(1,002)


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
DDS Segment	2022		2021		2022		2021		2023		2022
Net income (loss) attributable to DDS Segment	$	(324)	$	1,092	$	(211)	$	3,078	$	(641)	$	763
Provision for income taxes		265		353		1,196		599		215		533
Interest expense, net		(1)		4		1		17		62		3
Gain on loan forgiveness		-		-		-		(580)
Depreciation and amortization		201		139		483		459		225		224
Severance**										33		-
Stock-based compensation		761		404		1,929		863		806		371
Non-controlling interests		1		1		2		(2)		3		-
Adjusted EBITDA - DDS Segment	$	903	$	1,993	$	3,400	$	4,434
Adjusted EBITDA									$	703	$	1,894


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
Synodex Segment	2022		2021		2022		2021		2023		2022
Net loss attributable to Synodex Segment	$	(779)	$	(537)	$	(2,244)	$	(650)
Net income (loss) attributable to Synodex Segment									$	14	$	(785)
Depreciation and amortization	$	171		19	$	483	$	21		162		41
Severance**										6		-
Stock-based compensation		30		24		129		38		58		49
Non-controlling interests		-		(48)		(74)		(61)		-		(75)
Adjusted EBITDA (loss) - Synodex Segment	$	(578)	$	(542)	$	(1,706)	$	(652)
Adjusted EBITDA / (loss)									$	240	$	(770)


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
Agility Segment	2022		2021		2022		2021		2023		2022
Net loss attributable to Agility Segment	$	(2,224)	$	(1,355)	$	(7,520)	$	(2,933)	$	(1,489)	$	(2,793)
Provision for income taxes		3		(25)		97		22		3		(58)
Interest expense, net		-		-		-		1		1		-
Depreciation and amortization		639		526		1,870		1,574		704		608
Severance**										541		-
Stock-based compensation		14		75		312		216		98		117
Adjusted EBITDA (loss) - Agility Segment	$	(1,568)	$	(779)	$	(5,241)	$	(1,120)
Adjusted EBITDA (loss)									$	(142)	$	(2,126)

**Represents non-recurring severance incurred for a reduction in headcount in connection with the re-alignment of the Company’s cost structure.

2730

Table of Contents

Results of Operations

~~Amounts~~The amounts in the MD&A below ~~are after elimination of any inter-segment profit and~~ have been rounded. All percentages have been calculated using rounded amounts.

Three Months Ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021~~

Revenues

Total revenues were ~~$18.4~~$18.8 million and ~~$17.5~~$21.2 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$0.9~~$2.4 million or approximately 6%11%.

Revenues from the DDS segment were ~~$12.8~~$12.7 million and ~~$13.3~~$15.9 million for the three months ended ~~September 30,~~March 31, 2023 and March 31, 2022, ~~and 2021,~~ respectively, a decrease of ~~$0.5~~$3.2 million or approximately 4%20%. The decrease was primarily attributable to lower volume from ~~two existing customers.~~one customer offset in part by an increase in volume from another customer.

Revenues from the Synodex segment were ~~$1.8~~$1.9 million and ~~$1.0~~$1.7 million for the three months ended ~~September 30,~~March 31, 2023 and March 31, 2022, ~~and 2021,~~ respectively, an increase of ~~$0.8~~$0.2 million or approximately ~~80%~~12%. The increase was primarily attributable to higher volume from ~~two~~ existing customers.

Revenues from the Agility segment were ~~$3.8~~$4.2 million and ~~$3.2~~$3.6 million for the three months ended ~~September 30,~~March 31, 2023 and March 31, 2022, ~~and 2021,~~ respectively, an increase of $0.6 million or approximately ~~19%~~17%. The increase was ~~primarily~~principally attributable to higher volumes from subscriptions to our Agility AI-enabled industry platform and newswire product.

NoOne customer in the DDS segment generated ~~10% or more~~approximately 11% and another customer in the DDS segment generated 11% of the Company’s total revenues for the three months ended ~~September 30, 2022. One~~March 31, 2023. Another customer in the DDS segment generated approximately ~~10%~~21% of the Company’s total revenues for the three months ended ~~September 30, 2021.~~March 31, 2022. No other customer accounted for 10% or more of total revenues during these periods. Further, for the three months ended March 31, 2023 and 2022, revenues from non-U.S. customers accounted for ~~35%~~39% and ~~46%~~37% respectively, of the Company’s total ~~revenues for the three months ended September 30, 2022 and 2021, respectively.~~revenues.

Direct Operating Costs

Direct operating costs consist of direct and indirect labor costs, occupancy costs, data center hosting fees, cloud services, content acquisition costs, depreciation and amortization, travel, telecommunications, computer services and supplies, realized gain (loss) on forward contracts, foreign currency revaluation gain (loss), and other direct expenses that are incurred in providing services to our customers.

Direct operating costs were ~~$12.4~~$12.9 million and ~~$10.7~~$13.4 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$1.7~~$0.5 million or ~~16%~~4%. The cost ~~increase~~decrease was primarily ~~supported our growth initiatives across all business segments.~~due to lower revenues and cost optimization efforts aimed at improving operational efficiency and the Company’s ability to scale and respond to market conditions. The ~~increase~~decrease in ~~Direct~~direct operating costs includes ~~an increase in~~lower direct and indirect labor related costs amounting to $1.8 million primarily on account of ~~higher~~reductions in headcount, ~~and~~offset in part by salary increases and severance; unfavorable impact of ~~$1.0~~foreign exchange rate fluctuations of $0.8 million, ~~an increase in cloud services, content costs, and~~higher depreciation and amortization of capitalized developed software of ~~$0.5~~$0.1 million and ~~severance costs of $0.4 million, partially offset by a $0.2 million decrease~~an increase in other direct operating ~~costs.~~costs of $0.4 million. Direct operating costs as a percentage of total revenues were ~~67%~~69% and ~~61%~~63% for the three-month periods ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021.~~respectively. The increase in direct operating ~~costs~~cost as a percentage of total revenues was primarily ~~attributable~~due to ~~higher expenditures~~lower revenues in ~~all segments,~~the DDS segment, offset in part by ~~increased revenues~~lower direct operating costs in the DDS and Synodex ~~and Agility~~ segments.

Table of Contents

Direct operating costs for the DDS segment were approximately ~~$8.0~~$8.6 million and ~~$7.7~~$9.3 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$0.3~~$0.7 million or 4%8%. The cost ~~increase~~decrease was primarily ~~supported our growth initiatives.~~due to lower revenues and cost optimization efforts aimed at improving operational efficiency and the Company’s ability to scale and respond to market conditions. The ~~increase~~decrease in ~~Direct~~direct operating costs includes ~~an increase in severance costs of $0.4 million, an increase in cloud services, content costs, and depreciation and amortization of capitalized developed software of $0.1 million, an increase in~~lower direct and indirect labor related costs amounting to $1.9 million primarily, on account of ~~$0.1 million,~~reductions in headcount, offset in part by ~~a $0.1 million reduction due the~~salary increases and severance; unfavorable impact of foreign exchange ~~rates~~rate fluctuations ~~and a decrease~~of $0.8 million, an increase in other direct operating costs of ~~$0.2~~$0.4 million. Direct operating costs for the DDS segment as percentage of DDS segment revenues were 68% and 58% for the three months ended March 31, 2023 and 2022, respectively. The increase in direct operating costs of the DDS segment as a percentage of DDS segment revenues ~~were 63% and 58% for the three-month periods ended September 30, 2022 and 2021, respectively. The increase in direct operating costs as a percentage of segment revenues~~ was primarily attributable to ~~an increase~~lower revenues, offset in part by lower direct operating ~~costs and a decrease in revenues.~~costs.

Direct operating costs for the Synodex segment were ~~$2.2~~$1.7 million and ~~$1.2~~$1.9 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$1.0~~$0.2 million or ~~83%~~11%. The cost ~~increase primarily supported our growth initiatives combined with the timing of new technology roll-out. The increase in Direct operating costs~~decrease was primarily due to lower direct labor costs of $0.3 million, offset in part by an increase in other direct ~~labor~~operating costs

~~Table~~ of ~~Contents~~

~~primarily on account of higher headcount and salary increases of $0.8 million, and an increase in depreciation and amortization of capitalized developed software of $0.2~~$0.1 million. Direct operating costs for the Synodex segment as a percentage of Synodex segment revenues were ~~122%~~89% and ~~120%~~112% for the ~~three-month periods~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The ~~increase~~decrease in direct operating costs of the Synodex segment as a percentage of Synodex segment revenues was due to an increase in revenues and a decrease in direct operating ~~costs offset in part by an increase in revenues.~~costs.

Direct operating costs for the Agility segment were ~~$2.2~~$2.6 million and ~~$1.8~~$2.2 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, an increase of $0.4 million or ~~22%~~18%. The cost increase was primarily due to higher revenues and cost optimization efforts aimed at improving operational efficiency and the Company’s ability to scale and respond to market conditions. The cost increase was primarily due to an increase in direct labor costs of $0.4 million including severance higher depreciation and amortization of capitalized developed software ~~and content costs of $0.2 million, an increase in direct and indirect labor related costs primarily on account of higher headcount and salary increases~~ of $0.1 million, ~~and an unfavorable impact of foreign exchange rate fluctuations~~offset in part by a decrease in other direct operating costs of $0.1 million. Direct operating costs for the Agility segment as a percentage of Agility segment revenues were ~~58%~~62% and ~~56%~~61% for the ~~three-month periods~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The increase in direct operating costs of the Agility segment as a percentage of Agility segment revenues was primarily due to an increase in direct operating costs, offset in part by increased revenues from subscriptions to our Agility AI-enabled platform and newswire products.

Gross Profit and Gross Margin

Gross profit is derived by revenues less direct operating costs, while Gross margin in percentage is derived by dividing gross profit over revenues.

Gross profit was $6.0 million for the three months ended March 31, 2023 compared to $7.8 million for the three months ended March 31, 2022. The $1.8 million decrease in gross profit was primarily due to lower revenues in the DDS segment, offset in part by lower direct operating costs. Gross margin was 32% and 37% for the three months ended March 31, 2023 and 2022, respectively. The decrease in gross margin was primarily due to lower revenues in the DDS segment, offset in part by lower direct operating costs.

Gross profit for the DDS segment was $4.2 million for the three months ended March 31, 2023 compared to $6.6 million for the three months ended March 31, 2022. The $2.4 million decrease in gross profit for the DDS segment was primarily due to lower revenues, offset in part by lower direct operating costs. Gross margin for the DDS segment was 33% and 41% for the three months ended March 31, 2023 and 2022, respectively. The decrease in gross margin for the DDS segment was primarily due to lower revenues, offset in part by lower direct operating costs.

Gross profit for the Synodex segment was $0.2 million for the three months ended March 31, 2023 compared to a loss of $0.2 million for the three months ended March 31, 2022. The $0.4 million increase in gross profit for the Synodex segment was primarily due to higher revenues and lower direct operating costs. Gross margin for the Synodex segment was 11% and (14%) for the three months ended March 31, 2023 and 2022, respectively. The increase in gross margin for the Synodex segment was primarily due to higher revenues and lower direct operating costs.

Table of Contents

Gross profit for the Agility segment was $1.6 million for the three months ended March 31, 2023 compared to $1.5 million for the three months ended March 31, 2022. The $0.1 million increase in gross profit for the Agility segment was primarily due to higher revenues, offset in part by higher direct operating costs. Gross margin for the Agility segment was 38% and 40% for the three months ended March 31, 2023 and 2022, respectively. The decrease in gross margin for the Agility segment was primarily due to higher direct operating costs, offset in part by higher revenues.

Selling and Administrative Expenses

Selling and administrative expenses consist of sales, marketing, ~~product~~new services research and related software development, ~~and~~ administrative payroll and related costs including commissions, bonuses, ~~and~~ stock-based compensation, marketing costs, ~~new services research and related software development,~~ third-party software, advertising, trade conferences, professional fees and consultant costs, and other administrative overhead costs.

Selling and administrative expenses were ~~$9.1~~$7.8 million and ~~$7.3~~$10.2 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$1.8~~$2.4 million or ~~25%~~24%. The ~~cost increase primarily supported our growth initiatives across all business segments. The~~decrease in selling and administrative expenses was primarily due to the cost ~~increase~~optimization efforts aimed at improving operational efficiency and the Company’s ability to scale and respond to market conditions. The decrease in selling and administrative expenses includes ~~payroll~~lower selling and administrative labor and related ~~costs for new hires, stock-based compensation, commissions, incentives, bonuses,~~expenses of $0.9 million, primarily on account of headcount reduction, offset in part by salary increases and severance; lower recruitment and professional fees of $1.0 million, marketing ~~activity related cost~~expenses of ~~$0.3 million, severance costs of $0.3~~$0.5 million and ~~an unfavorable impact~~leasehold improvement write-offs from lease terminations of ~~foreign exchange rate fluctuations~~$0.2 million. These lower selling and administrative expenses were also offset in part by higher provisions for doubtful accounts of $0.2 million. Selling and administrative expenses as a percentage of total revenues were ~~49%~~41% and ~~42%~~48% for the ~~three-month periods~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The ~~increase~~decrease in selling and administrative expenses as a percentage of total revenues was primarily attributable to ~~higher~~lower expenditures in all segments, offset in part by ~~increased~~lower revenues in the ~~Agility and Synodex segments.~~DDS segment.

Selling and administrative expenses for the DDS segment were ~~$4.8~~$4.5 million and ~~$4.1~~$5.3 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$0.7~~$0.8 million or ~~17%~~15%. The ~~cost increase primarily supported our growth initiatives. The~~decrease in selling and administrative expenses was primarily due to the cost ~~increase~~optimization efforts aimed at improving operational efficiency and the Company’s ability to scale and respond to market conditions. The decrease in selling and administrative expenses includes ~~payroll~~lower administrative and selling labor and related ~~costs for new hires, stock-based compensation, commissions, incentives, bonuses,~~expenses of $0.1 million, primarily on account of headcount reductions; lower recruitment and ~~recruitment fees of $0.4 million, an increase in~~ professional fees of $0.5 million, and a decrease in other selling and administrative expenses of $0.2 million, primarily from lower marketing expenses and ~~marketing activity related costs of $0.1 million.~~lower provision for doubtful accounts. Selling and administrative expenses for the DDS segment as a percentage of DDS segment revenues were ~~38%~~35% and ~~31%~~33% for each of the three-month periods ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The increase in selling and administrative expenses of the DDS segment as a percentage of ~~total~~DDS segment revenues was primarily attributable to ~~higher expenditures~~lower revenues, offset in part by lower selling and ~~decreased revenues.~~administrative expenses.

Selling and administrative expenses for the Synodex segment were ~~$0.4~~$0.2 million and ~~$0.3~~$0.6 million for the three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$0.1~~$0.4 million or ~~33%~~67%. The ~~cost increase~~decrease in selling and administrative expenses was primarily attributable to ~~payroll related costs and recruitment~~lower professional fees ~~for new hires $0.1~~of $0.3 million and ~~marketing activity related~~lower payroll-related costs of ~~$0.1 million to support our growth initiatives. These costs were~~$0.2 million; offset by an increase in ~~part by a decrease in professional fees~~other selling and administrative expenses of $0.1 million. Selling and administrative expenses for the Synodex segment as a percentage of Synodex segment revenues were ~~22%~~11% and ~~30%~~35% for the ~~three-month periods~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The decrease in selling and administrative expenses of the Synodex segment as a percentage of Synodex segment revenues was primarily attributable to ~~higher revenues~~lower selling and administrative expenses, offset in part by higher ~~expenditures.~~

Selling and administrative expenses for the Agility segment were $3.9 million and $2.9 million for the three months ended September 30, 2022 and 2021, respectively, an increase of $1.0 million or 34%. The cost increase primarily supported our growth initiatives. The selling and administrative costs increase includes payroll related costs for new hires, stock-based compensation, commissions, incentives of $0.5 million, severance costs of $0.3 million, an unfavorable impact of foreign exchange rate fluctuations of $0.2 million, an increase in marketing activity related costs of $0.1 million, offset in part by a decrease in professional fees of $0.1 million. Selling and administrative expenses for the Agility segment as a percentage of Agility segment revenues were 103% and 91% for the three-month periods ended September 30, 2022 and 2021, respectively. The increase in selling and administrative expenses as a percentage of segment revenues was primarily due to higher expenditures, offset in part by an increase in revenues.

2933

Table of Contents

~~Income Taxes~~

~~We recorded a provision for income taxes of $0.3 million for the three months ended September 30, 2022 and 2021.~~

Taxes primarily consist of a provision for foreign taxes recorded in accordance with the local tax regulations by our foreign subsidiaries. Effective income tax rates are disproportionate due to the losses incurred by our U.S. entity and our Canadian subsidiaries, and a valuation allowance recorded on deferred taxes on these entities and tax effects of foreign operations, including foreign exchange gains and losses.

~~Net Income (Loss)~~

We incurred a net loss of $3.3 million during the three months ended September 30, 2022, compared to a net loss of $0.8 million during the three months ended September 30, 2021. The $2.5 million change was a result of higher Direct operating costs and Selling and administrative expenses in all segments in the current quarter, offset in part by higher revenues in the Synodex and Agility segments and a favorable impact of foreign currency exchange rates.

Net loss for the DDS segment was $0.3 million for the three months ended September 30, 2022, compared to a net income of $1.2 million for the three months ended September 30, 2021. The $1.5 million change was primarily attributable to a decrease in revenues and an increase in Direct operating costs and Selling and administrative expenses in the current quarter.

Net loss for the Synodex segment was $0.8 million for the three months ended September 30, 2022, compared to a net loss of $0.5 million for the three months ended September 30, 2021. The $0.3 million change was due to higher Direct operating costs and Selling and administrative expenses, offset in part by higher revenues in the current quarter.

Net loss for the Agility segment was $2.2 million for the three months ended September 30, 2022, compared to net loss of $1.5 million for the three months ended September 30, 2021. The $0.7 million change was due to higher Direct operating costs and Selling and administrative expenses, offset in part by higher revenues in the current quarter and a favorable impact of foreign currency exchange rates.

~~Adjusted EBITDA~~

Adjusted EBITDA for the three months ended September 30, 2022 was a loss of $1.2 million compared to an income of $0.7 million for the three months ended September 30, 2021. The $1.9 million change in Adjusted EBITDA was due to a higher net loss reduced in part by higher stock-based compensation and depreciation and amortization.

Adjusted EBITDA for the DDS segment was $0.9 million and $2.0 million for the three months ended September 30, 2022 and 2021, respectively. The $1.1 million change in Adjusted EBITDA was due to lower net income for the DDS segment, offset in part by higher stock-based compensation.

Adjusted EBITDA for the Synodex segment was a loss of $0.6 million and $0.5 million for the three months ended September 30, 2022 and 2021, respectively. The $0.1 million change was due to a higher net loss for the Synodex segment, offset in part by higher depreciation and amortization.

Adjusted EBITDA for the Agility segment was a loss of $1.6 million and $0.8 million for the three months ended September 30, 2022 and 2021, respectively. The $0.8 million change in Adjusted EBITDA was due to a higher net loss for the Agility segment, offset in part by higher depreciation and amortization.

~~Nine Months Ended September 30, 2022 and 2021~~

~~Revenues~~

~~Total revenues were $59.6 million and $50.5 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $9.1 million or approximately 18%.~~

Revenues from the DDS segment were $42.9 million and $38.0 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $4.9 million or approximately 13%. The increase was primarily attributable to higher volume from an existing customer.

~~Table of Contents~~

Revenues from the Synodex segment were $5.4 million and $2.9 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $2.5 million or approximately 86%. The increase was primarily attributable to higher volume from two existing customers.

Revenues from the Agility segment were $11.3 million and $9.6 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $1.7 million or approximately 18%. The increase was primarily attributable to higher volumes from subscriptions to our Agility AI-enabled industry platform and newswire product.

~~Direct Operating Costs~~

Direct operating costs were $38.8 million and $31.2 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $7.6 million or 24%. The cost increase primarily supported our growth initiatives across all business segments. The increase in Direct operating costs includes direct and indirect labor related costs primarily on account of higher headcount and salary increases of $6.2 million; an increase in cloud services, occupancy, content costs, depreciation and amortization of capitalized developed software of $1.2 million; severance cost of $0.4 million, and an increase in other direct operating costs of $0.5 million; offset in part by a $0.7 million reduction due the impact of foreign exchange rates fluctuations. Direct operating costs as a percentage of total revenues were 65% and 62% for the nine-month periods ended September 30, 2022 and 2021. The increase in direct operating costs as a percentage of total revenues was primarily attributable to higher expenditures in all segments, offset in part by increased revenues in all segments.

Direct operating costs for the DDS segment were approximately $26.3 million and $23.1 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $3.2 million or 14%. The cost increase primarily supported our growth initiatives. The increase in Direct operating costs includes direct and indirect labor related costs primarily on account of higher headcount and salary increases of $3.1 million; severance cost of $0.4 million and an increase in cloud services, occupancy, and depreciation and amortization of capitalized developed software of $0.2 million, and an increase in other direct operating costs of $0.4 million; offset in part by $0.9 million due the impact of foreign exchange rates fluctuations. Direct operating costs for the DDS segment as percentage of DDS segment revenues was 61% for each of the nine-month periods ended September 30, 2022 and 2021, respectively. There was no change in direct operating costs as a percentage of segment revenues as the increase in direct operating costs was offset by an increase in revenues.

Direct operating costs for the Synodex segment was $6.2 million and $2.7 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $3.5 million or 130%. The cost increase primarily supported our growth initiatives combined with the timing of new technology roll-out. The increase in Direct operating costs was primarily due to an increase in direct labor costs on account of higher headcount and salary increases of $2.9 million and an increase in depreciation and amortization of capitalized developed software of $0.6 million. Direct operating costs for the Synodex segment as a percentage of Synodex segment revenues were 115% and 93% for the nine-month periods ended September 30, 2022 and 2021, respectively. The increase in direct operating costs as a percentage of segment revenues was due to an increase in direct operating costs offset in part by an increase in revenues.

Direct operating costs for the Agility segment were $6.3 million and $5.4 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $0.9 million or 17%. The cost increase was primarily due to higher amortization of capitalized developed software and content costs of $0.4 million higher labor related costs of $0.2 million, an unfavorable impact of foreign exchange rate fluctuations of $0.2 million and an increase in other direct operating costs of $0.1 million. Direct operating costs for the Agility segment as a percentage of Agility segment revenues was 56% for each of the nine-month periods ended September 30, 2022 and 2021, respectively. There was no change in direct operating costs as percentage of segment revenues as the increase in direct operating costs were offset by an increase in revenues.

~~Table of Contents~~

~~Selling and Administrative Expenses~~

Selling and administrative expenses consist of sales, marketing, product research and development and administrative payroll and related costs including commissions, bonuses, and stock-based compensation, marketing costs, new services research and related software development, third-party software, advertising, trade conferences, professional fees and consultant costs, and other administrative overhead costs.

Selling and administrative expenses were $29.6 million and $19.8 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $9.8 million or 49%. The cost increase primarily supported our growth initiatives across all business segments. The selling and administrative cost increase includes payroll related costs for new hires, stock-based compensation, commissions, incentives, and bonuses of $5.7 million, marketing activity related costs of $2.3 million, recruitment and professional fees of $1.1 million, severance costs of $0.3 million, an unfavorable impact of foreign exchange rate fluctuations of $0.2 million and a $0.2 million increase in other selling and administrative costs. Selling and administrative expenses as a percentage of total revenues were 50% and 39% for the nine-month periods ended September 30, 2022 and 2021, respectively. The increase in selling and administrative expenses as a percentage of total revenues was primarily attributable to higher expenditures in all segments, offset in part by increased revenues in all segments.

Selling and administrative expenses for the DDS segment were $15.6 million and $11.8 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $3.8 million or 32%. The cost increase primarily supported our growth initiatives. The selling and administrative cost increase includes payroll related costs for new hires, stock-based compensation, commissions, incentives, and bonuses of $2.1 million, marketing activity related costs of $1.0 million, recruitment and professional fees of $0.7 million. Selling and administrative expenses for the DDS segment as a percentage of DDS revenues were 36% and 31% for the nine-month periods ended September 30, 2022 and 2021, respectively. The increase in selling and administrative expenses as a percentage of total revenues was primarily attributable to higher expenditures offset in part by increased revenues.

Selling and administrative expenses for the Synodex segment were $1.5 million and $0.9 million for the nine months ended September 30, 2022 and 2021, respectively, an increase of $0.6 million or 67%. The cost increase was primarily attributable to payroll related costs and recruitment fees for new hires and other professional fees of $0.6 million to support our growth initiatives. Selling and administrative expenses for the Synodex segment as a percentage of Synodex segment revenues were 28% and 31% for the nine-month periods ended September 30, 2022 and 2021, respectively. The decrease in selling and administrative expenses as a percentage of segment revenues was primarily attributable to lower expenditures offset in part by higher revenues.

Selling and administrative expenses for the Agility segment were ~~$12.5~~$3.1 million and ~~$7.1~~$4.3 million for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively, ~~an increase~~a decrease of ~~$5.4~~$1.2 million or ~~76%~~28%. The ~~cost increase primarily supported our growth initiatives. The~~decrease in selling and administrative ~~costs increase~~expenses was primarily due to the cost optimization efforts aimed at improving operational efficiency and the Company’s ability to scale and respond to market conditions. The decrease in selling and administrative expenses includes ~~payroll~~lower selling and administrative labor and related ~~costs for new hires, stock-based compensation, commissions, incentives~~expenses of ~~$3.6~~$0.6 million, ~~marketing activity related costs~~primarily on account of ~~$1.3 million, severance costs of $0.3 million, an unfavorable impact of foreign exchange rate fluctuations~~headcount reduction and severance; lower recruitment and professional fees of $0.2 million, marketing expenses of $0.4 million, and aleasehold improvement write-offs from lease terminations of $0.2 ~~million increase in other~~million. These lower selling and administrative ~~costs; partly~~expenses were also offset in part by ~~decreases in recruitment and professional fees~~a higher provision for doubtful accounts of $0.2 million. Selling and administrative expenses for the Agility segment as a percentage of Agility segment revenues were ~~111%~~74% and ~~74%~~119% for the ~~nine-month periods~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The ~~increase~~decrease in selling and administrative expenses of the Agility segment as a percentage of Agility segment revenues was primarily due to ~~higher expenditures,~~lower selling and administrative expenses, offset in part by an increase in revenues.

~~Gain on PPP Loan forgiveness~~

On May 4, 2020, the Company received loan proceeds of $579,700 under the Paycheck Protection Program (“PPP”) which was established as part of the Coronavirus Aid, Relief and Economic Security Act of 2020, as amended. On May 21, 2021, the Company’s loan forgiveness application was approved for 100% of the amount loaned to the Company by the Small Business Administration (“SBA”).

Income Taxes

We recorded a provision for income taxes of ~~$1.3~~$0.2 million and $0.5 million for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~as compared to $0.6 million for the nine months ended September 30, 2021.~~respectively.

~~Taxes~~Tax-related charges primarily ~~consist~~consisted of a provision for foreign taxes recorded in accordance with ~~the~~ local tax regulations by our foreign subsidiaries. Effective income tax rates are disproportionate primarily due to ~~the~~ losses incurred by our U.S. ~~entity~~entities, Canadian and ~~our Canadian~~European principally (Germany and the United Kingdom) subsidiaries, and a valuation allowance recorded on the deferred taxes ~~on these entities~~of the U.S., Canadian, German and the United Kingdom subsidiaries.

Net Loss

We incurred a net loss of $2.1 million and $2.8 million during the three months ended March 31, 2023 and 2022, respectively. The $0.7 million change was a result of lower operating costs in all segments in the current quarter, offset in part by higher revenues in the Synodex and Agility segments.

Net loss for the DDS segment was $0.6 million for the three months ended March 31, 2023, compared to a net income of $0.8 million for the three months ended March 31, 2022. The $1.4 million change was primarily attributable to lower revenues in the current quarter offset in part by lower operating costs and lower tax ~~effects~~provision.

The Synodex segment was breakeven for the three months ended March 31, 2023, compared to a net loss of ~~foreign operations, including foreign exchange gains~~$0.8 million for the three months ended March 31, 2022. The $0.8 million change was due to lower operating costs, offset in part by higher revenues in the current quarter.

Net loss for the Agility segment was $1.5 million for the three months ended March 31, 2023, compared to a net loss of $2.8 million for the three months ended March 31, 2022. The $1.3 million change was due to higher revenues, lower selling and ~~losses.~~administrative costs, offset in part by higher direct operating costs in the current quarter.

Adjusted Gross Profit

Adjusted gross profit for the three months ended March 31, 2023 was $7.4 million compared to $8.7 million for the three months ended March 31, 2022. The $1.3 million decrease in adjusted gross profit is due to a lower gross profit, offset in part by higher depreciation and amortization, and non- recurring severance. Adjusted gross margin was 39% and 41% for the three months ended March 31, 2023 and 2022, respectively. The decrease in adjusted gross margin was due to a lower gross profit, offset in part by higher depreciation and amortization, and non-recurring severance.

Adjusted gross profit for the DDS segment was $4.4 million and $6.8 million for the three months ended March 31, 2023 and 2022, respectively. The $2.4 million decrease in adjusted gross profit for the DDS Segment is due to lower gross profit, offset in part by higher non-recurring severance. Adjusted gross margin for the DDS segment was 35% and 43% for the three months ended March 31, 2023 and 2022, respectively. The decrease in the adjusted gross margin for the DDS segment was due to lower gross profit, offset in part by higher non-recurring severance.

3234

Table of Contents

~~Net Income (Loss)~~

~~We incurred a net loss of $10.0 million and $0.5 million during~~Adjusted gross profit for the ~~nine~~Synodex segment for the three months ended ~~September 30, 2022 and 2021. The $9.5~~March 31, 2023 was $0.4 million ~~change was~~compared to a ~~result~~loss of higher Direct operating and Selling and administrative costs in all segments in the current nine-month period, offset in part by higher revenues in all segments and a favorable impact of foreign currency exchange rates.

~~Net loss for the DDS segment was~~ $0.2 million for the ~~nine~~three months ended ~~September 30, 2022, compared to a net income of $3.1~~March 31, 2022. The $0.6 million ~~for the nine months ended September 30, 2021. The change of $3.3 million was primarily attributable to an~~ increase in ~~Direct operating costs and Selling and administrative expenses, offset in part by an increase in revenues~~adjusted gross profit in the ~~current nine-month period~~Synodex segment is due to higher gross profit and ~~a favorable impact of foreign currency exchange rates.~~

~~Net loss~~higher depreciation and amortization. Adjusted gross margin for the Synodex segment was ~~$2.2 million~~20% and (11%) for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~compared to a net loss of $0.7 million~~respectively. The increase in the adjusted gross margin for the ~~nine months ended September 30, 2021. The $1.5 million change~~Synodex segment was due to higher ~~Direct operating costs~~gross profit and ~~Selling~~higher depreciation and ~~administrative expenses, offset in part by higher revenues in the current nine-month period.~~amortization.

~~Net loss~~Adjusted gross profit for the Agility segment was ~~$7.6~~$2.6 million and $2.1 million for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~compared to net loss of $2.9~~respectively. The $0.5 million increase in adjusted gross profit for the ~~nine~~Agility segment is due to higher gross profit, higher non-recurring severance, and depreciation and amortization. Adjusted gross margin for the Agility segment was 62% and 57% for the three months ended ~~September 30, 2021.~~March 31, 2023 and 2022, respectively. The ~~$4.7 million change~~increase in the adjusted gross margin for the Agility segment was due to higher ~~Direct operating costs~~gross profit, higher non-recurring severance, and ~~Selling~~depreciation and ~~administrative expenses, offset in part by higher revenues in the current nine-month period and a favorable impact of foreign currency exchange rates.~~amortization.

Adjusted EBITDA

Adjusted EBITDA for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 was $0.8 million compared to a loss of ~~$3.5 million compared to an income of $2.6~~$1.0 million for the ~~nine~~three months ended ~~September 30, 2021.~~March 31, 2022. The ~~$6.1~~$1.8 million ~~change~~increase in Adjusted EBITDA was due to a ~~higher~~lower net loss, ~~reduced~~higher stock-based compensation, and higher depreciation and amortization and non-recurring severance, offset in part by ~~higher provisions for income taxes, stock-based compensation, depreciation and amortization.~~a lower tax provision.

Adjusted EBITDA for the DDS segment was ~~$3.4~~$0.7 million and ~~$4.4~~$1.9 million for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The ~~$1.0~~$1.2 million ~~change~~decrease in Adjusted EBITDA ~~was due to lower net income~~ in the DDS ~~segment,~~Segment is due to a higher net loss and lower tax provision, offset in part by higher stock-based compensation and ~~provision for income taxes.~~higher non-recurring severance.

Adjusted EBITDA for the Synodex segment for the three months ended March 31, 2023 was $0.2 million compared to a loss ~~$1.7 million and $0.7~~of $0.8 million for the ~~nine~~three months ended ~~September 30, 2022 and 2021, respectively.~~March 31, 2022. The $1.0 million ~~change~~increase in Adjusted EBITDA ~~was due to a higher net loss~~ in the Synodex segment ~~offset in part by~~is due to a lower net loss and higher depreciation and amortization.

Adjusted EBITDA for the Agility segment was a loss of ~~$5.2~~$0.1 million and ~~$1.1~~loss of $2.1 million for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ respectively. The ~~$4.1~~$2.0 million ~~change~~increase in Adjusted EBITDA ~~was due to a higher net loss~~ in the Agility segment ~~offset in part by~~is due to a lower net loss and higher depreciation and ~~amortization.~~amortization and non-recurring severance.

Adjusted Gross Profit, Adjusted Gross Margin and Adjusted EBITDA ~~is a~~are non-GAAP financial ~~measure.~~measures. For a reconciliation of Adjusted Gross Profit, Adjusted Gross Margin and Adjusted EBITDA to the most directly comparable GAAP measure, please see the description of “Non-GAAP Financial Measures – Adjusted Gross Profit and Adjusted Gross Margin, and Adjusted EBITDA” above.

Liquidity and Capital Resources

Selected measures of liquidity and capital resources, expressed in thousands, were as follows:


	September 30,		December 31,		March 31,		December 31,
	2022		2021		2023		2022
Cash and cash equivalents	$	10,729	$	18,902	$	10,330	$	9,792
Short term investments - other						512		507
Working capital		2,992		12,658		2,323		2,869

~~At September 30, 2022,~~On March 31, 2023, we had cash and cash equivalents of ~~$10.7~~$10.3 million and short-term investments of $0.5 million, of which ~~$4.9~~$3.1 million was held by our foreign subsidiaries, and ~~$5.8~~$7.2 million was held in the United States. The short-term investments of $0.5 million were held in the United States. Despite ~~our ability under existing~~the passage of the new tax law tounder which we may repatriate funds from overseas after paying the toll charge, it is our intent, as of ~~September 30, 2022,~~March 31, 2023, to indefinitely reinvest the overseas funds in our foreign subsidiaries ~~on account of~~due to the withholding tax that we would have to incur on the actual remittances.

Table of Contents

We have used, and plan to use, our cash and cash equivalents for (i) capital investments; (ii) the expansion of our operations; (iii) technology innovation; (iv) ~~hiring of sales personnel; (v)~~ product management and strategic marketing; ~~(vi)~~(v) general corporate purposes, including working capital; and ~~(vii)~~(vi) possible business acquisitions. WeAs of March 31, 2023, we had working capital of approximately ~~$3.0~~$2.3 million, ~~and~~

~~Table~~as compared to working capital of ~~Contents~~

~~$12.7~~approximately $2.9 million as of ~~September 30, 2022 and~~ December 31, ~~2021, respectively.~~2022. The decrease in working capital ~~was~~is due to aadditional accruals for severance costs and payroll related taxes offset in part by decrease in ~~cash used to fund our growth initiatives.~~accounts receivable, accounts payable and accrued expenses during the three months ended March 31, 2023.

We did not have any material commitments for capital expenditures as of ~~September 30, 2022.~~March 31, 2023.

We believe that our existing cash and cash equivalents and internally generated funds will provide sufficient sources of liquidity to satisfy our financial needs for at least the next 12 months from the date of this Report. ~~However,~~On April 4, 2023, we ~~have no bank facilities or lines~~entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as lender, Innodata Synodex, LLC, Innodata docGenix, LLC, and Agility PR Solutions LLC. The Credit Agreement provides for a secured revolving line of ~~credit. A decrease~~credit (the “Revolving Credit Facility”) up to an amount equal to the lesser of the borrowing base and $10.0 million with a maturity date of April 4, 2026. The Revolving Credit Facility’s borrowing base is calculated in accordance with the terms of the Credit Agreement and on the basis of 85% of eligible accounts, 85% of eligible foreign accounts up to $2.0 million and certain other reserves and adjustments. As of the date of entry into the Credit Agreement, such borrowing base calculation equaled approximately $3.3 million. Reference is made to Note 15, “Subsequent Events” in the condensed consolidated financial statements of this Report, which is incorporated by reference herein. Any material decreases in our cash and cash equivalents from operating losses, capital expenditures, adverse legal decisions, acquisitions or otherwise could materially and adversely affect the Company.

Cash Flows

Net Cash ~~Used in~~Provided by (Used in) Operating Activities

Cash ~~used in~~provided by our operating activities for the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 was ~~$1.7~~$1.8 million primarily on account of the following factors: our net loss for the period of ~~$10.0~~$2.1 million; a source of ~~$6.1~~$2.3 million from non-cash expenses consisting of depreciation and amortization of ~~$2.8~~$1.1 million, stock-based compensation of ~~$2.4~~$1.0 million, pension ~~cost~~costs of ~~$0.6 million,~~$0.3 million; partially offset by a decrease in deferred ~~tax provisions of $0.2 million and a loss~~taxes of $0.1 ~~million from the termination of one of our operating lease contracts.~~million. Net changes from working capital accounts ~~contributed~~further sourced an additional ~~$2.2~~$1.6 million in working capital, mainly from a decrease in accounts receivable of ~~$1.7~~$1.1 million, a decrease in prepaid expenses and other current assets of ~~$0.7~~$0.2 million; an increase in accrued salaries, wages and related benefits of $0.6 million and an increase in income and other taxes of $0.3 million; offset in part by a ~~$0.2 million net~~ decrease in accounts payable, accrued expenses and other ~~working capital accounts.~~of $0.6 million. Refer to the condensed consolidated statements of cash flows for further details.

Cash ~~provided by~~used in our operating activities for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 was ~~$5.6~~$1.5 million primarily on account of the following factors: our net loss for the period of ~~$0.6~~$2.9 million; a source of ~~$2.9~~$1.6 million from non-cash expenses consisting of depreciation and amortization of ~~$2.1~~$0.9 million, stock-based compensation of ~~$1.1~~$0.5 million, a loss of $0.1 million on termination of one of our operating lease contracts and ~~pension cost of $0.3~~$0.1 million ~~offset in part by a gain on loan forgiveness of $0.6 million.~~due to other non-cash transactions. Net changes from working capital accounts further ~~contributed~~utilized an additional ~~source~~$0.2 million in working capital, mainly from an increase in accounts payable and accrued expenses of ~~$3.3~~$0.5 million and an increase in accrued salaries, wages and related benefits of $0.4 million; offset in part by a decrease in accounts receivable of $0.5 million and a net reduction in other working capital accounts of $0.2 million. Refer to the condensed consolidated statements of cash flows for further details.

Net Cash Used in Investing Activities

For the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022, ~~and 2021,~~ cash used in our investing activities was ~~$5.3~~$1.7 million and ~~$3.0~~$1.9 million, respectively. These capital expenditures were principally for the purchase of technology equipment including servers, network infrastructure and workstations, and expenditures for capitalized developed ~~software~~software.

During the next 12 months, it is anticipated that capital expenditures for capitalized developed software and ongoing technology, equipment and infrastructure upgrades will approximate to ~~$6.4~~$6.5 million, a portion of which we may finance.

Table of Contents

Net Cash ~~Used in~~Provided by (Used in) Financing Activities

Cash provided by financing activities for the three months ended March 31, 2023 was primarily from proceeds of stock option exercises of $0.3 million.

Cash used in financing activities for the ~~nine~~three months ended ~~September 30,~~March 31, 2022 was ~~$0.2 million~~ primarily for payments of long-term obligations of ~~$0.5 million, reduced~~$39,000, offset in part by proceeds from stock option exercises of ~~$0.3 million.~~

~~Cash provided by financing activities for the nine months ended September 30, 2021 was $0.8 million from proceeds from stock option exercises~~$26,000 and redemption of ~~$2.2 million. Cash paid for withholding taxes on net settlement exercises~~non-controlling interest of ~~stock options for the nine months ended September 30, 2021 was $0.8 million. Payments of long-term obligations were $0.6 million for the nine months ended September 30, 2021.~~$1,000.

Critical Accounting Policies and Estimates

Our discussion and analysis of our results of operations, liquidity and capital resources is based on our condensed consolidated financial statements, which have been prepared in conformity with U.S. GAAP. The preparation of the condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, allowance for doubtful accounts and billing adjustments, long-lived assets, intangible assets, goodwill, valuation of deferred tax assets, value of securities underlying stock-based compensation, litigation accruals, pension benefits, ~~purchase price allocation of Agility,~~ valuation of derivative instruments and estimated accruals for various tax exposures. We base our estimates on historical and anticipated results and trends and on various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and

~~Table of Contents~~

liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from our estimates and could have a significant adverse effect on our condensed consolidated results of operations and financial position.

The significant accounting policies used in preparing our condensed consolidated financial statements contained in this Report are the same as those described in the Company’s Annual Report on Form 10-K, unless otherwise noted, and we believe those critical accounting policies affect our more significant estimates and judgments in the preparation of our condensed consolidated financial statements.

Off-Balance Sheet Arrangements

None.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable for smaller reporting companies.

Item 4. Controls and Procedures

We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act), that are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision, and with the participation of our management, including our principal executive officer and our principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures, as defined under Exchange Act Rule 13a-15(e), as of ~~September 30, 2022.~~March 31, 2023. Based on this evaluation, our principal executive officer and our principal financial officer concluded that, as of ~~September 30, 2022,~~March 31, 2023, our disclosure controls and procedures were effective.

There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during the ~~nine~~three months ended ~~September 30, 2022~~March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial ~~reporting~~

reporting.

3537

Table of Contents

PART II.OTHER INFORMATION

Item 1. Legal Proceedings

See Note 4,8, Commitments and Contingencies of the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q, which is incorporated by reference herein.

Item 1A. Risk Factors

~~There were no material changes from the risk factors previously disclosed in~~For information regarding Risk Factors, please refer to Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022, as supplemented by the following additional risk factors, which shall be deemed to replace, in its entirety, the risk factor in our Annual Report on Form 10-K entitled, “We have no bank facilities or line of credit.”

Debt under our Revolving Credit Facility has a variable rate of interest that is based on SOFR which may have consequences for us that cannot be reasonably predicted and may increase our cost of borrowing in the future.

Debt outstanding under our Revolving Credit Facility has a variable rate of interest that is based on the secured overnight financing rate (“SOFR”) which may have consequences for us that cannot be reasonably predicted and may increase our cost of borrowing in the future. The future performance of SOFR cannot be predicted based on historical performance and the future level of SOFR may have little or no relation to historical levels of SOFR. Any patterns in market variable behaviors, such as correlations, may change in the future. Hypothetical or historical performance data are not indicative of, and have no bearing on, the potential performance of SOFR.

Our Revolving Credit Facility contains restrictive covenants that may impair our ability to conduct business.

Our Revolving Credit Facility contains operating covenants and financial covenants that may in each case limit management’s discretion with respect to certain business matters. For example, the Revolving Credit Facility contains a financial covenant that requires us, on a consolidated basis, to maintain a fixed charge coverage ratio of not less than 1.10 to 1.00 by December 31, 2023. As a result of these covenants and restrictions, we may be limited in how we conduct our business, and we may be unable to raise additional debt or other financing to compete effectively or to take advantage of new business opportunities. The terms of any future indebtedness we may incur could include more restrictive covenants. Failure to comply with such restrictive covenants may lead to default and acceleration under our Revolving Credit Facility and may impair our ability to conduct business. We may not be able to maintain compliance with these covenants in the future and, if we fail to do so, there are no assurances that we will be able to obtain waivers from the lender and/or amend the covenants.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no sales of unregistered equity securities or repurchases of equity securities during the three months ended ~~September 30, 2022.~~March 31, 2023.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

3638

Table of Contents

Item 6.Exhibits

Exhibit No.		Description

10.1		Credit Agreement, dated as of April 4, 2023, by and among Innodata Inc., Innodata Synodex, LLC, Innodata Docgenix, LLC, and Agility PR Solutions LLC as borrowers, and Wells Fargo Bank, National Association, as lender (incorporated herein by reference to Exhibit 10.1 to the 8-K filed with the Securities and Exchange Commission on April 5, 2023).

10.2		Security Agreement, dated as of April 4, 2023, by and among Innodata Inc., Innodata Synodex, LLC, Innodata Docgenix, LLC, and Agility PR Solutions LLC as grantors, and Wells Fargo Bank, National Association, as secured party (incorporated herein by reference to Exhibit 10.2 to the 8-K filed with the Securities and Exchange Commission on April 5, 2023).

10.3		Guaranty, dated as of April 4, 2023, by and among Innodata Inc., Innodata Synodex, LLC, Innodata Docgenix, LLC, and Agility PR Solutions LLC as guarantors, and Wells Fargo Bank, National Association, as lender (incorporated herein by reference to Exhibit 10.3 to the 8-K filed with the Securities and Exchange Commission on April 5, 2023).

31.1*		Certificate of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certificate of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1; **		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2; **		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		The following materials from Innodata Inc.’s Quarterly Report on Form 10-Q for the three months ended ~~September 30, 2022,~~March 31, 2023, formatted in Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets as of ~~September 30, 2022~~March 31, 2023 (unaudited) and December 31, ~~2021;~~2022; (ii) Condensed Consolidated Statements of Operations and Comprehensive ~~Income (Loss)~~Loss for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021;~~(unaudited); (iii) Condensed Consolidated Statements of Cash Flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2023 and 2022 ~~and 2021;~~(unaudited); (iv) Condensed Consolidated Statements of Stockholders’ Equity for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2023 and 2022 and ~~2021;~~ (v) Notes to Condensed Consolidated Financial Statements (unaudited).

104		Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.

*	Filed herewith.

**	In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

3739

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

INNODATA INC.


Date:	~~November 10, 2022~~May 11, 2023	/s/ Jack S. Abuhoff

		Jack S. Abuhoff
		Chief Executive Officer and President

Date:	~~November 10, 2022~~May 11, 2023	/s/ Marissa B. Espineli

		Marissa B. Espineli
		Interim Chief Financial Officer
		(Principal Financial Officer and
		Principal Accounting Officer)

3840


	Nine Months Ended
	September 30,
	2022		2021
Revenues	$	59,626	$	50,466
Operating costs and expenses:
Direct operating costs		38,795		31,208
Selling and administrative expenses		29,584		19,767
Interest expense, net		1		18
		68,380		50,993
Loss from operations		(8,754)		(527)
Gain from loan forgiveness		-		580
Income (loss) before provision for income taxes		(8,754)		53
Provision for income taxes		1,293		621
Consolidated net loss		(10,047)		(568)
Loss attributable to non-controlling interests		(72)		(63)
Net Loss attributable to Innodata Inc. and Subsidiaries	$	(9,975)	$	(505)

Loss per share attributable to Innodata Inc. and Subsidiaries:
Basic and Diluted	$	(0.37)	$	(0.02)

Weighted average shares outstanding:
Basic and Diluted		27,239		26,459

Comprehensive Loss:
Consolidated Net loss	$	(10,047)	$	(568)
Pension liability adjustment, net of taxes		113		32
Foreign currency translation adjustment		(1,270)		(480)
Change in fair value of derivatives, net of taxes		(742)		(532)
Other comprehensive loss		(1,899)		(980)
Total Comprehensive loss		(11,946)		(1,548)
Less: Comprehensive loss attributable to non-controlling interests		(72)		(63)
Comprehensive Loss attributable to Innodata Inc. and Subsidiaries	$	(11,874)	$	(1,485)


											Capitalized Developed
	Company Acquired Intangible Assets										Software
													Capitalized
					Trademarks				Media		Capitalized		Developed
	Developed		Customer		and				Contact		Developed		Software - in
	technology		relationships		tradenames		Patents		Database		Software		Progress		Total
Gross carrying amounts:
Balance as of January 1, 2022	$	3,169	$	2,228	$	880	$	45	$	3,648	$	8,576	$	635	$	19,181
Additions		-		-		-		-		-		-		4,244		4,244
Transfers		-		-		-		-		-		2,882		(2,882)		-
Foreign currency translation		(235)		(162)		(42)		(3)		(284)		(656)		(12)		(1,394)
Balance as of September 30, 2022	$	2,934	$	2,066	$	838	$	42	$	3,364	$	10,802	$	1,985	$	22,031

Accumulated amortization:
Balance as of January 1, 2022	$	2,158	$	1,377	$	685	$	34	$	2,005	$	2,575	$	-	$	8,834
Amortization expense		235		139		42		3		267		1,286		-		1,972
Foreign currency translation		(175)		(110)		(30)		(3)		(170)		(229)		-		(717)
Balance as of September 30, 2022	$	2,218	$	1,406	$	697	$	34	$	2,102	$	3,632	$	-	$	10,089

Net carrying values - September 30, 2022	$	716	$	660	$	141	$	8	$	1,262	$	7,170	$	1,985	$	11,942


	Number of Restricted	Weighted-Average Grant
	Stock Awards	Date Fair Value
Unvested at January 1, 2022	25,000	$	1.38
Granted	-		-
Vested	(25,000)		1.38
Forfeited/Expired	-		-
Unvested at September 30, 2022	-	$	-